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ABSTRACT 
 
Evaluation of Anticancer Potential of Sorghums with Different Genetic Characteristics 
and Levels of Phenolic Compounds. (May 2008) 
Sara Guajardo Flores, B.A., Instituto Tecnológico y de Estudios Superiores de 
Monterrey; M.S., Texas A&M University 
Co-Chairs of Advisory Committee:  Dr. Lloyd W. Rooney 
Dr. Sergio Serna-Saldívar 
 
To evaluate the anticancer potential of sorghum phenolic compounds, different 
experiments including in vitro and in vivo tests were performed. A set of 25 sorghum 
samples was evaluated for phenolic (total phenols, flavonoids, anthocyanins and 
tannins) content, hydrophilic and lipophilic antioxidant capacity using de Oxygen 
Radical Absorbance Capacity assay (ORAC), and screened for citotoxic properties in 
mammary, colon and hepatic mammalian cancer cell lines in vitro. Results indicated 
that there was a wide variability in the phytochemical profile among the different 
sorghums. Among the 25 samples, sumac sorghum bran had the highest amount of 
phenolic compounds, flavonoids, tannins and the highest ORAC values. It exerted the 
highest percent inhibition (near 100%) in mammary, colon and liver cancer cell lines. 
Sumac sorghum bran was selected for further investigation.  Methanolic extracts from 
sumac whole grain, bran and tannin removed bran were tested in vitro at different 
concentrations in hormone dependent MCF-7 mammary cancer cells and non hormone 
dependent Caco2 and HepG2 colon and liver cancer cells. Results indicated that the 
methanolic extract from sumac bran inhibited 100% of MCF-7 cancer cells at a 
concentration of 0.5 mg/ml and that the citotoxic effect could be partially due to the 
tannin content of the extract. Concentrations of 0.5 and 1.5 mg/ml were selected for an 
in vivo preventive cancer study with 7,12-dymethylbenz(a)-anthracene (DMBA) induced 
female rats. Bran at low and high concentrations and the correspondent amount of 
methanol extracts were included in the diet. It was observed that sumac methanol 
extract at low concentration promoted tumor appearance and development, whereas 
sumac bran had a preventive effect, however, there were no significant differences in 
rats treated and un-treated with sumac. Differences between in vitro and in vivo results 
iv 
 
could be due to the degree of absorption of tannins during the in vivo experiment. To 
obtain additional data about the effect of sumac extracts on cancer development, a 
quinone reductase enzyme bioassay was performed. Methanol and hexane extracts 
from sumac bran induced phase II enzymes in vitro. Phytochemicals of sumac bran 
sorghum including phenolic compounds and lipid like compounds appeared to have 
potential for cancer prevention.  
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CHAPTER I 
INTRODUCTION 
 
Cancer is one of the main causes of death in the USA and the world. In 2004, cancer 
was the second cause of death in the USA, just below cardiovascular diseases, with 
553, 888 deaths. In women, breast cancer is the second most important cause of 
cancer related deaths. It was estimated that in 2007,  about 1.4 million new cases of 
cancer were diagnosed, cancers of the prostate and breast being the most frequently 
diagnosed in men and women, respectively, followed by lung and colorectal cancers 
both in men and in women (American Cancer Society  2007). 
 
Cancer chemoprevention is an approach that has been studied for the last years in 
order to address the disease. Many natural compounds have been studied; among 
them phenolic compounds from fruits and vegetables have been extensively studied for 
their antioxidant properties related to oxidative stress and cancer prevention. Cancer 
preventive phytochemicals have been shown to suppress or block carcinogenesis by a 
variety of mechanisms including acting as antioxidants or antiproliferative agents 
(Singletary and others 2003). Polyphenols are reducing agents, and together with other 
dietary reducing agents, referred to as antioxidants, protect the body´s tissues against 
oxidative stress and associated pathologies such as cancers, coronary heart disease 
and inflammation (Tapiero and others 2002). 
 
Sorghum is a cereal   grown in different parts of the world, it has economically 
advantages over other grains such as drought resistance, water efficiency, with 
significant low levels of fumonisins and aflatoxins. Some sorghum varieties have been 
screened for its phenolic composition.  These compounds are mainly localized in the 
bran in amounts sometimes equal or greater than the most studied vegetal products. 
The phenolic compounds of sorghum can be divided into three basic groups: simple 
phenolics, flavonoids, and tannins. All sorghums contain phenolic acids and most 
contain flavonoids, but only certain varieties contain tannins (Hahn and others 1984). 
____________ 
This dissertation follows the style of Journal of Food Science. 
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There is plenty of literature relating polyphenol-rich foods properties with the prevention 
of various types of cancers and oxidative stress, however, the information related to 
sorghum is too limited to draw reasonable conclusions. In vitro data as well as 
controlled animal studies are necessary to understand how the levels and composition 
of polyphenols in sorghum prevent cancer, and which specific components are 
responsible (Awika and Rooney 2004). The objective of the present study is to evaluate 
the potential of sorghum phenolic compounds as inhibitors of cancer cell growth and 
phase II enzymes induction in vitro and their chemopreventive properties on tumor 
development after 7,12-dimethylbenz[a]anthracene (DMBA)-initiation of female rats. 
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CHAPTER II 
SCREENING AND CHARACTERIZATION OF DIFFERENT SORGHUMS FOR 
ANTICANCER POTENTIAL 
 
Literature Review 
 
Sorghum 
 
Sorghum [Sorghum bicolor (L.) Moench] is one of the most important cereals in the 
world, more than 35% is grown directly for human consumption (in Asia and Africa is 
used primarily as a food crop), the rest is used for animal feed, alcohol and industrial 
products; generally is more economical to produce, resist drought and other 
environmental stresses (Awika and Rooney 2004).  
 
Sorghum kernel, as the rest of the cereals, consists of three anatomical components: 
pericarp (outer layer), endosperm (storage tissue) and germ (embryo). The proximate 
composition of sorghums varies due to genetics and environment, but it is well known 
that the pericarp is rich in fiber, whereas the germ is high in protein, fat and ash. The 
endosperm contains mostly starch, some protein and small amounts of fat and fiber. 
Below the pericarp of sorghum is the seed coat or testa, in certain types of sorghum, 
phenols and tannins are concentrated in this part. The endosperm is composed of the 
aleurone layer, peripheral, and corneous and floury areas (depending on the 
arrangement of starch and protein). Germ consists of the embryonic axis and scutellum. 
(Rooney and Waniska  2000). 
 
Based upon their genetics and chemical analysis sorghum varieties can be divided into 
three different groups: Types I, II and III. Type I sorghums do not have a pigmented 
testa, therefore contain low levels of phenols and are practically devoid of tannins. 
Types II and III have a pigmented testa and contain considerable levels of condensed 
tannins. Tannins from Type II sorghums are extracted with acidified methanol (1%HCL 
methanol) while tannins in Type III are extracted with either methanol or acidified 
methanol (Dykes and Rooney 2006). 
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Sorghum phytochemicals 
 
In recent years sorghum has attracted attention and has been studied because it is a 
potential source of different phytochemicals. Phytochemicals are defined as bioactive 
nonnutrient plant compounds associated to fruits, vegetables, grains, and other plant 
foods that have been linked to reducing the risk of major chronic diseases (Liu 2004). 
Sorghum contains phenolic compounds, waxes (lipid compounds), phytosterols and 
proteins that have been related to health benefits.  
 
Phenolic compounds 
 
Phenolics are compounds possessing one or more aromatic rings with one or more 
hydroxyl groups. They are the products of secondary metabolism in plants, in many 
cases are formed as defense mechanisms. These compounds exert their beneficial 
effects as free radical scavengers and chelators of pro-oxidant metals, these features 
have relate the consumption of foods rich in phenolic compounds with reduced health 
problems. 
 
Some sorghum varieties contain phenolic compounds in amounts that equals or exceed 
the ones reported for fruits and vegetables. The amount and type of phenols varies 
between cultivars and is influenced by genotype and environment in which it is grown 
(Dykes and others 2005). Phenols in sorghum fall under two categories: phenolic acids 
and flavonoids including tannins (Awika and Rooney 2004).  
 
Phenolic acids consist of two classes: hydroxybenzoic and hydroxycinnamic. 
Hydroxybenzoic acids are derived from benzoic acid and include gallic, protocatehuic, 
p-hydroxybenzoic, gentisic, salicylic, vanillic and syringic acids. Hydrozycinnamic acids 
include ferulic, caffeic, p-coumaric, cinnamic and sinapic acids. Phenolic acids are 
located in the pericarp, testa, aleurone layer (free phenolics) and endosperm of the 
kernel (bound phenolics) (Dykes and Rooney 2006). 
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The major flavonoids studied in sorghum include tannins and anthocyanins. 
Anthocyanins of sorghum are called 3-deoxyanthocyanins, because they lack a 
hydroxyl group in the 3-position of the C-ring (Dykes and Rooney 2006), the two 
common 3-deoxyanthocyanins are the apigeninindin (yellow) and the luteolinidin 
(orange) (Awika and others 2004). Anthocyanins are concentrated in the bran; 
sorghums with a black pericarp have the highest amount of 3-deoxyanthocyanins 
reported. 
 
Tannins (proanthocyanidins) occur only in the outer layers of the kernel (pericarp, 
pigmented testa and glumes) of some Type II or III sorghums (Rooney and Waniska 
2000). These tannins are of the condensed type, hydrolysable tannins have never been 
found in sorghum. Levels of tannins vary among genotypes, in general, Type II and III 
sorghums have tannin levels of 0.02-0.19mg/100mg and 0.4-3.5mg/100mg catechin 
equivalents, respectively. 
 
Waxes 
 
Waxes are defined as esters formed between long chain fatty acids and long chain 
alcohols; plant waxes contain besides wax esters, non esterified very long chain 
hydrocarbons, alcohols, aldehydes and acids (Hargrove and others 2004). Traditionally 
food waxes includes that from cereal grains, nuts, unrefined oil, sugar cane and honey.  
Wax compounds as octacosanol has been related to cholesterol lowering properties. In 
sorghum, wax comprises about 0.2-0.3% of the kernel, is mainly formed of long chain 
aldehydes. The major components of the long-chain lipids are policosanols (40%), 
aldhehydes (50%) and acids (4%). Octacosanol (28:0) and triacontanol (30:0) 
comprises over 80% of the policosanols in sorghum grain, other components are 
hexacosanol (26:0), dotriacontanol (36:0), lignoceryl alcohol (24:0) and nonacosanol 
(29:0) (Hwang and others 2004). Christiansen and others (2007) reported that sorghum 
grain contains besides policosanols, other health-promoting lipids as phytosterols, and 
omega 3-fatty acids. Phytosterols are cholesterol like compounds that are structural 
components of plant cell membranes. In sorghum the free phytosterols identified 
include sitosterol, campesterol and stigmasterol (Awika and Rooney 2004). 
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Proteins 
 
Kafirin is the main storage protein in sorghum, three classes of kafirin: the ,  and  
forms have been identified at the protein level, they are the most hydrophobic of the 
prolamins and exhibit extensive cross-linking by disulphide bonds. Certain kafirin () 
has been studied as a compound that prevents blood vessels narrowing (Kamath and 
others 2005) 
 
 
Materials and Methods 
 
Different sorghum samples (Table 1) were characterized for phenolic, flavonoids, 
anthocyanins and tannin content (Robledo and others 2007). Samples included whole 
grain and bran from different sorghums (Type I, Type II and Type III) (Robledo and 
others 2007). To measure the antioxidant capacity the ORAC assay was performed. 
Samples were then screened for anticancer potential using in vitro colon (Caco 2), liver 
(HepG2) and hormone-dependent mammary cancer (MCF-7) cell lines. 
 
Sample preparation 
Whole grain samples or bran samples were ground through a cyclotec mill (UDY Corp. 
Fort Collins, CO) equipped with a 1 mm mesh. To obtain bran, sorghum (sumac and 
black) was decorticated and milled using procedures described by Awika and others 
(2005). Cleaned representative sorghum samples were decorticated using the 
tangential abrasive dehulling device (TADD) (model 4E-230, Venable Machine Works, 
Saskatoon, Canada) for a total of 6 min to obtain bran. Percent removal was 12% and 
was calculated as [initial sample weight – decorticated grit weight/ initial sample weight].  
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Table 1 – Set of sorghum samples selected for characterization and in vitro 
screening 
 
Sample ID Sample Name Sorghum Type Location Year 
CQL 01 ATX635 x RTX 436 1 College Station 2001 
CQL 02 SC748 1 Lubbock 2005 
CQL 03 Hegari 2 College Station 2003 
CQL 04 TX2911 1 College Station 2005 
CQL 05 TX430 Black 1 College Station 2001 
CQL 06 PI Black Tall 3 College Station 2005 
CQL 07 Sumac 3 College Station 2005 
CQL 08 Sumac Bran 3 College Station 2005 
CQL 09 TX430 Black Bran 1 College Station 2001 
CQL 10 SC719-11E 3 College Station 2005 
CQL 11 SC650 1 College Station 2005 
CQL 12 BRON 176 1 Lubbock 2005 
CQL 13 SC109-14E 3 College Station 2005 
CQL 14 Shawaya (Mostly Black) 1 College Station 2005 
CQL 15 Shawaya (Brownie Tan) 3 College Station 2005 
CQL 16 NK 121 A 3 UMES 2004 
CQL 17 NK 180 3 UMES 2004 
CQL 18 NK 8830 3 UMES 2004 
CQL 19 XM 217 3 UMES 2004 
CQL 20 EBA 3 1 Lubbock 2005 
CQL 21 SC575 2 College Station 2005 
CQL 22 SC103 3 College Station 2005 
CQL 23 SC630ii 1 College Station 2005 
CQL 24 SC1038 1 College Station 2005 
CQL 25 SC630 II 1 College Station 2005 
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Sample extraction for characterization of phenolic content, flavonoids, anthocyanins 
and hydrophilic ORAC determination 
 
Sample (1 g) was extracted with 80% aqueous methanol (10ml) for 4 hr at room 
temperature under continuous agitation at 200 rpm. The resulting sample-solvent mix 
was filtered through Whatman No. 1 filter paper in a Buchner funnel under vacuum and 
the solvent recovered. The spent grain was then washed four consecutive times with 
80% methanol to assure the complete removal of the soluble compounds. Resulting 
extracts were used for phenolic content, flavonoids, anthocyanins, tannins and 
hydrophilic ORAC determination. 
 
Total phenolic content determination 
 
Total phenolic content of sorghum samples was measured using a procedure similar to 
the one reported by Wolfe and others (2003). The method is a modified colorimetric 
Folin-Ciocalteu. A volume of 20 µl of methanol extract was added to a test tube. Folin-
Ciocalteu reagent (200 µl) was added to the solution and allowed to react for 5 min. 
Then, 1.27 ml of 7% sodium carbonate solution was placed into test tubes, and the 
mixture was diluted to 3 ml with deionized water. The color developed for 20 min, and 
the absorbance was read at 750 nm using a spectrophotometer (Beckman Coulter DU 
800 Beckman Coulter Inc, Fullerton California U.S.A.). The measurement was 
compared to a curve prepared with standard gallic acid solutions and expressed as 
milligrams of gallic acid equivalents per gram. 
 
Flavonoid content determination 
 
Flavonoid content of sorghum samples was measured using a modified colorimetric 
method reported by Wolfe and others (2003). A diluted methanol extract (20 µl), 
prepared as described previously, was added to a test tube containing 100 µl of distilled 
water. A 5% sodium nitrite solution (6 µl) was added to the mixture and allowed to stand 
for 5 min. Then, 12 µl of 5% aluminum chloride was added. After 6 min, 40 µl of 1 M 
sodium hydroxide was added, and the mixture was diluted with another 22 µl of distilled 
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water. Absorbance of the mixture was immediately measured at 510 nm using a 
spectrophotometer Beckman Coulter DU 800 (Beckman Coulter Inc, Fullerton California 
U.S.A.) and compared to a curve prepared with standard catechin solutions. The 
flavonoid content was expressed as milligrams of catechin equivalents per gram.  
 
Anthocyanin content 
 
Anthocyanin content of sorghum samples was measured using a pH differential 
protocol reported by Wolfe and others (2003). Sorghum methanol extracts were mixed 
thoroughly with 0.025 M potassium chloride pH 1 buffer in 1:3 or 1:8 ratio of extract to 
buffer. Then the absorbance was measured at 515 and 700 nm against a distilled water 
blank. Sorghum extracts were then combined similarly with sodium acetate buffer pH 
4.5, the absorbance of these solutions was measured at the same wavelengths. 
Anthocyanin content was calculated as follows:  Total monomeric anthocyanin (mg /100 
g sample) = AxMWx1000/(xC) where A is absorbance = (A515 – A700)pH1 – (A515 – 
A700)pH 4.5; MW is molecular weight of cyaniding 3-glucoside = 449.2.  is the molar 
absorptivity of cyanidin 3-glucoside = 26900; and C is the concentration of the buffer in 
milligrams per milliliter. Anthocyanin content was expressed as milligrams of cyanidin 3-
glucoside equivalents per g of sample.  
 
Tannin content determination 
 
Tannins were determined on sorghum samples following the method suggested by 
Price and others (1978) with some modifications. Extracts of sorghum samples were 
prepared by continuously rotating 200 mg of ground grain with 10 ml of 80% aqueous 
methanol in test tubes at room temperature for 20 min. Methanol extracts were 
dissolved in water and an aliquot of vanillin reagent was added. Absorbance was 
measured at 500 nm using a spectrophotometer Beckman Coulter DU 800 (Beckman 
Coulter Inc, Fullerton California U.S.A.). Tannin content was expressed as milligrams of 
catechin equivalents per g of sample. 
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Antioxidant activity quantification by the Oxygen Radical Absorbance Capacity (ORAC) 
assay 
 
Lipophilic and hydrophilic ORAC assays were performed essentially following the 
procedure by Prior and others (2003). Ground samples (1 g) were extracted with 10ml 
of hexane for 4 hr at room temperature. A sonicator (SC-15OT, Sonicor Instrument 
Corporation, NY, USA) was used to enhance extraction. The resulting sample-solvent 
mix was filtered and the solvent recovered. Spent grain was washed four consecutive 
times. Solvent was then evaporated by a nitrogen flush and the resulting solids 
resuspended in 50% aqueous acetone. Hydrophilic assay was performed in 80% 
aqueous methanol extracts. For the lipophilic assay, dried hexane extract was dissolved 
in acetone followed by RMCD solution. For the hydrophilic assay dilutions were made 
with a phosphate buffer. A SynergyTM HT Multi-Detection microplate reader (Bio-Tek 
Instruments, Inc., Winooski, VT) was used with fluorescence filters set to an excitation 
wavelength of 485 ± 20 nm and an emission wavelength of 530 ± 25 nm. The plate 
reader was controlled by KC4 3.0 software. Antioxidant activity was expressed as 
µmoles of Trolox per gram of sample.  
 
Sample extraction for in vitro analysis 
 
Samples were extracted with aqueous methanol (80%). Solvent (50 ml) was added to 5 
g of sample in a 250 ml flask and placed in the shaker for 3 h at 150 rpm at 25°C for 
extraction. Samples were filtered through Whatman 1 filter paper in a Buchner funnel 
under vacuum, filtrate was concentrated using a rotary evaporator Yamato RE200 ( 
Yamato Scientific America Inc., Orangeburg, N.Y. U.S.A.) set at 40°C to near dryness 
and then lyophilized with  a Freezemobile FM25EL-85 (SP Industries, Germany) 
remove water. Dry samples were labeled as crude extracts and stored at -80°C until 
analysis. 
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In vitro cancer assay 
 
MCF-7 breast, HepG2 liver and Caco-2 colon cancer cells were cultured as described 
by Romo-Lopez, (2005). Cell viability was estimated by trypan blue exclusion test. A 
100 µl Cells (1 x 105 cell/ml) were injected in a 96-well plate, maintained in Dulbecco´s 
modified Eagle´s medium (DMEM) containing 10% fetal calf serum (FCS) and 100 U/ml 
penicillin, and 100 µg/ml streptomycin. After 24 h incubation at 37ºC under a humidified 
5% carbon dioxide atmosphere to allow cell attachment, cells were treated with 
sorghum crude extracts and incubated for 72 h under same conditions. (Romo-Lopez 
2005) 
 
Methanolic extracts were used to measure the ability of sorghum samples to inhibit 
cancer cell proliferation. Cell cultures were exposed to 0.5 mg /ml concentration of the 
extracts. Cell proliferation was measured using the CellTiter 96® AQueous One Solution 
Cell Proliferation (Promega Corporation, Madison, WI) colorimetric based assay. Cell 
proliferation was measured by the ability of viable cells to reduce 3-(4,5-dimethylthiazol-
2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfenyl)-2H-tetrazolium (MTS) to formazan. The 
absorbance at 490nm was measured using a SynergyTM HT Multi-Detection microplate 
reader (Bio-Tek Instruments, Inc., Winooski, VT). 
 
Statistical analysis 
 
For the characterization and screening part results are means of 3 determinations ± 
standard error. Data were analyzed using a Microsoft Excel (Microsoft, 2007) 
spreadsheet. 
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Results and Discussion 
 
The phenolic content of 25 different samples was evaluated. Among samples, sample 
#8 corresponding to the sumac bran, had the highest amount of phenolic compounds 
followed by sample #7 sumac grain and sample #9 black bran (Figure 1). Sumac is a 
type III, brown sorghum with pigmented testa with high amounts of phenolic compounds 
(Awika and others 2005). Compared to sumac sorghum which had almost 12 mg of 
gallic acid equivalents (GAE), sumac bran had approximately 17 mg. This was 
expected, since phenolic compounds are concentrated in the outer layers of the kernel 
(Awika and others 2005), and therefore the abraded bran would have the compounds 
concentrated. Sample 9, which is also a bran but from black sorghum, had values of 
approximately 8 mg.  
 
Samples of whole grains were classified by the presence and absence of the pigmented 
testa and the pericarp color (Figure 1). Sorghum samples with pigmented testa had in 
general higher values of mg GAE. Sorghum samples without pigmented testa and black 
pericarp had an average value of 2.8 mg of GAE, samples with red or yellow pericarp 
and no testa had average values of 2.3 mg of GAE. A white sorghum (sample 1) had 
the lowest content of phenolics. Values of GAE were in general lower than values 
previously reported for the same samples, this was especially true for sorghums 
samples with pigmented testa that had an average GAE 3.45 vs 10.72 (Unpublished 
data, CQL). Differences in phenol content determination can be attributed to the method 
of extraction. Extraction of samples for Folin-Ciocalteu are commonly performed in 80% 
acetone, in this case extraction was made with 80% methanol. For this study samples 
for total phenols, flavonoids, anthocyanins, tannins and hydrophilic ORAC were 
extracted in 80% methanol in order to have the same extract composition analyzed and 
tested in the cancer cells.  
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Figure 1 - Total phenol content of sorghum samples. Samples are grouped by 
pericarp color and the presence/absence of pigmented testa. Sample 1 is a white 
sorghum without testa. The characteristic of each sorghum entry tested is in 
Table 1. Error bars denote standard error. 
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Flavonoid, anthocyanin, and tannin contents were determined to characterize the type 
of phenolic compounds present in each sample. Flavonoids measured as mg of 
catechin equivalents (CE), were high for the bran samples 8 and 9 (Figure 2), sumac 
and black brans had 20 mg and 7 mg of CE respectively.  
 
The average value of flavonoids for type II and type III sorghums (pigmented testa) was 
1.68, this value was higher compared to red and yellow type I sorghums which had 
average values of 0.9 and 0.67 respectively. Black sorghums without pigmented testa 
had an average value of 1.44. Flavonoids reported in sorghum grains include 
anthocyanins (apigeninidin, luteolinidin), flavan-4-ols (luteoforol, apiforol), flavones 
(apigenin, luteolin), flavanones (eriodictyol, naringenin), flavonols (kaempferol), 
dihydroflavonols (taxifolin) proanthocyanidin monomer/dimmers (catechin, procyanidin 
B-1), and proanthocyanidin polymers (epicatechin) (Dykes and Rooney 2006). Type II 
and III sorghums had been recognized for their proanthocyanidin content, while black 
sorghums for the high amount of 3-deoxyanthocyanins (Dykes and Rooney 2006). 
 
Anthocyanin content of samples was determined (Figure 3). Sample 9, black bran 
sorghum had the highest amount of anthocyanin with approximately 67 mg of cyanidin 
equivalents per gram (CAE). Sample 6, another black sorghum but with pigmented 
testa, had approximately 16 mg CAE. Black sorghums contained significantly more 
anthocyanin pigments than other types of sorghums (Awika and others 2004). 
Apigeninidin and luteolinidin are the major 3-deoxyanthocyanins found in this type of 
sorghums (Dykes and Rooney 2006).  Sumac bran (sample 8) had almost 18 mg of 
CAE, the amount of anthocyanins in this sample can be attributed to a concentration 
effect. Sorghum with pigmented testa had an average of 5.31 mg of CAE. Luteolinidin 
and apigeninindin have been reported in red and brown sorghums (Dykes and Rooney 
2006).  
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Figure 2 – Flavonoid content of sorghum samples. Samples are grouped by 
pericarp color and the presence/absence of pigmented testa. Sample 1 is a white 
sorghum without testa. The characteristic of each sorghum entry tested is in 
Table 1. Error bars denote standard error.  
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Figure 3 – Anthocyanin content of sorghum samples. Samples are grouped by 
pericarp color and the presence/absence of pigmented testa. Sample 1 is a white 
sorghum without testa. The characteristic of each sorghum entry tested is in 
Table 1. Error bars denote standard error. 
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Tannins from sorghum are only of the condensed type, hydrolysable tannins have not 
been reported in sorghum, although some early authors reported data on tannic acid 
equivalents (Dykes and Rooney 2006). Sumac bran (sample 8) had the highest amount 
of tannins (247 mg CAE/ g sample), this was expected since brown type III sorghums 
have the highest amount of tannins, which are concentrated in the bran (Figure 4). 
Samples 7, 15, 16, 18, 19 and 22 type III sorghums had a tannin content of 17 to 86 mg 
of CE. In type I sorghums tannins were not detected. These results were previously 
reported. Sorghums with the B1_B2_ gene (type II and type III) contains tannins while 
type I contain no tannins (Dykes and Rooney 2006). Samples 3, 6, 10, 13, 17 and 21 
are also type III sorghums but tannins were not detected as it was expected. The tannin 
content of some of the samples was underestimated by the method of extraction used. 
For tannin extraction, aqueous methanol was used instead of acidic methanol. This 
decision was taken because at the beginning of the experiments we were expecting to 
correlate the flavonoid content of the samples with their antiproliferative effect on 
cancer cells. Another reason was that previously HCL showed a toxic effect on the 
cancer cell lines and HCL was difficult to remove from extracts without compromising 
the total phenolic content of the sample.  It is well known that acidic methanol is used to 
extract tannins from sorghums. Methanol is not as efficient in extracting tannins as the 
acidic methanol especially in type II sorghums where the pigmented material is 
deposited in vesicles instead of being deposited along the cell walls like in type III 
sorghums. This difference makes tannins more difficult to extract from type II sorghums 
(Earp and others 2004). Additionally it has been reported that water interferes with 
vanillin in the tannin determination method giving lower values of tannin content (Terrill 
and others 1990).  
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Figure 4 - Tannin content of sorghum samples. Samples are grouped by pericarp 
color and the presence/absence of pigmented testa. Sample 1 is a white sorghum 
without testa. The characteristic of each sorghum entry tested is in Table 1. Error 
bars denote standard error. 
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Phenolic and polyphenolic compounds had been recognized as potent natural 
antioxidants. The antioxidant capacity of these compounds have been related to health 
benefits such as counteracting the risk of cardiovascular diseases, cancer and cataract 
as well as a number of other degenerative diseases (Sahidi 2003).  
 
Extracts from different sorghums samples had high antioxidant activities (Table 2), 
ranging from 91.1 to 1088 trolox equivalents/g. Differences in antioxidant activity among 
the 25 samples could be related to the type and amount of phenolics present on each 
sample. Phenolic compounds includes phenolic acids, flavonoids (flavonols, flavones, 
catechins, anthocyanins) and tannins, and each type exert different antioxidant activity. 
The antioxidant capacity of an extract is dependent on the profile (type and amount) of 
phenolic compounds (Reyes and Cisneros 2007).  
 
Sumac sorghum had an ORAC value of 829, which is similar to values reported by 
Awika and others (2003), where sumac sorghum also had higher antioxidant activities 
than other samples. ORAC values for the sumac and black sorghum brans were 1133 
and 930 respectively, these values are higher since phenolic compounds are 
concentrated in the bran.  
 
For sumac bran (sample 8), it appears that tannin content is a considerable part of the 
phenolics reported in Figure 1. The high antioxidant activity of this sample could be 
related to the tannin content. Hagerman and others (2004) suggested that tannins are 
more potent antioxidants than simple monomeric phenolics. Tannins are likely 
responsible for the high activity in the brown sorghums (Awika and others 2003). It was 
expected that type II and III sorghum samples had higher average ORAC values than 
the type I sorghums since these samples had relatively no tannins. Results were not as 
expected probably because the use of aqueous methanol was not efficient for tannin 
extraction in all the samples and therefore the antioxidant capacity exerted by these 
compounds was affected, and not measured by the ORAC. For the samples were 
tannins were determined there was a positive correlation with the antioxidant capacity 
(Table 3), it is possible that this correlation were stronger if an efficient extraction of the 
tannins were achieved in all extracts.  
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Table 2 - ORAC values for the 25 sorghum sample set, sorghum type is included 
  
ORAC1 
 
Sample Description Hidrophilic Lipophilic H+L 
Sorghum 
Type 
1 
ATX635 x RTX 
436 228.79±19.57 20.40±0.53 249.19±20.11 1 
2 SC748 285.99±6.89 19.91±0.12 305.9±7.01 1 
3 Hegari 80.53±10.11 11.39±0.26 91.92±10.37 2 
4 TX2911 552.65±6.68 4.91±0.14 557.56±6.82 1 
5 TX430 Black 310.65±7.91 21.30±0.42 331.95±8.33 1 
6 PI Black Tall 243.32±2.82 27.44±1.38 270.76±4.20 3 
7 Sumac 811.74±6.80 17.21±0.43 828.95±7.23 3 
8 Sumac Bran 1139.09±31.5 25.78±2.31 1133.08±33.81 3 
9 TX430 Black Bran 920.04±31.41 24.90±1.56 920.04±32.97 1 
10 SC719-11E 600.34±50.77 20.87±0.47 621.21±51.24 3 
11 SC650 194.96±4.80 22.22±0.77 217.18±5.57 1 
12 BRON 176 364.71±5.61 25.37±0.45 390.08±6.06 1 
13 SC109-14E 95.34±2.91 20.43±0.90 115.77±3.81 3 
14 
Shawaya (Mostly 
Black) 244.81±5.39 22.70±0.99 267.51±6.38 1 
15 
Shawaya (Brownie 
Tan) 162.27±1.16 30.85±0.97 193.12±2.13 3 
16 NK 121 A 138.72±2.02 22.28±0.33 161±2.35 3 
17 NK 180 294.77±11.55 23.62±0.85 318.39±12.40 3 
18 NK 8830 334.67±3.88 16.68±0.49 351.35±4.37 3 
19 XM 217 302.86±10.26 19.32±0.40 322.18±10.66 3 
20 EBA 3 953.94±3.57 24.98±0.38 978.92±3.95 1 
21 SC575 951.38±33.59 12.36±0.39 963.74±33.98 2 
22 SC103 1035.43±34.12 18.51±0.99 1053.94±35.11 3 
23 SC630ii 442.23±9.28 15.80±0.64 458.03±9.92 1 
24 SC1038 1065.75±7.90 21.97±0.49 1087.72±8.39 1 
25 SC630 II 431.10±26.12 32.04±0.14 463.14±26.26 1 
1mmol TE (trolox equivalents)/g, values are the sum of hydrophilic and lipophilic 
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Samples 20 and 24, type I sorghums, had surprisingly high ORAC value of 987 and 
1087 respectively although they did not contain tannins or anthocyanins, and the 
amount of flavonoids and total phenols were also lower compared with other samples. 
These are lemon yellow pericarp sorghums, and it is possible that these specific 
samples had other high antioxidant compounds different from phenolic compounds 
exerting the antioxidant activity. Other high antioxidant compounds that have been 
detected in sorghum include carotenoids and tocopherols. Carotenoids are an important 
group of phytochemicals which has been recognized as natural antioxidants together 
with vitamin E (tocopherol), polyphenolics and flavonoids (Liu 2004). Carotenoid 
content of some sorghum cultivars has been reported to be 0.010 to 0.315 mg/kg. 
Among carotenoids, zeaxanthin has been recognized as the most abundant followed by 
lutein (Kean and others 2007);  tocopherol has also been detected in whole sorghum 
lipid extracts in concentrations of 0.219 to 0.577 µg/mg (Christiansen and others 2007). 
Non-polar compounds such as carotenes, xantophylls and tocopherols could be present 
in the methanol extracts even in small amounts. Choi and others (2006) studied the 
antioxidant contents and antioxidant activities of methanolic extracts from different 
grains including red sorghum. Extracts were prepared by placing 10g of ground grain 
with 200ml of methanol in a shaker for 24 h with subsequent centrifugation, evaporation 
and sample freeze storage. The polyphenol content for the red sorghum sample was 
733mg/100g gallic acid equivalents, per 100g. Carotenoids and tocopherols were also 
present in the extract in amounts of 22 µg and 1.79 mg/100g of sample respectively. It 
is possible then, that methanol extracts contained other compounds besides phenolics. 
 
Phenol contents of sorghums correlate strongly with their antioxidant activity measured 
either by the ABTS, DPPH or ORAC assays, Awika and others (2003) indicated that 
phenol contents of sorghum can be good predictors of their antioxidant activities. The 
ORAC method is reported to mimic antioxidant activity of phenols in biological systems 
better than other methods since it uses biologically relevant free radicals and integrates 
both time and degree of activity (Awika and others 2003). In this study, a good 
correlation between ORAC values (lipophilic+hydrophilic) (Table 2) and phenolic 
content was not found (Table 3), there was however a tendency, the higher the 
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phenolics (total phenols, flavonoids, anthocyanins and tannins) the higher the 
antioxidant capacity. Differences in these values with previous reports on sorghum 
could be due to the difference in the extraction procedures resulting in different 
amount/presence of phenolic compounds. Another reason that has been addressed 
previously (Kamath and others 2004; Wu and others 2004), is that there are other 
compounds besides phenolics measured by the Folin-Ciocalteu method that are 
responsible for the antioxidant activity. Wu and others (2004) reported that there are 
some foods were the correlation between total phenolics and ORAC values is not high, 
and this is the result from the presence of other compounds with antioxidant activity that 
are not phenolic, or because some phenolics are more effective than others.   
 
 
Table 3 - Correlation of tannins, total phenolics, anthocyanins, flavonoids and 
ORAC values of the 25 sorghum sample set with inhibition of three different 
cancer cell lines 
  
 
ORAC MCF-7 Caco2 HepG2 
 
h+l (breast) (colon) (liver) 
Tannins 0.61694 0.96596 0.96352 0.90840 
Total phenolics 0.52824 0.32321 0.67531 0.78371 
Anthocyanins 0.45071 -0.03231 0.96721 0.93595 
Flavonoids 0.46878 0.34875 0.62764 0.97806 
ORAC h+l . -0.28386 0.23715 0.87109 
 
 
 
A screening of the antiproliferative effect of methanol sorghum extracts at 0.5 mg/ml 
concentration on different cancer cell lines was performed. Antiproliferative in vitro 
screening models provides preliminary data to select extracts with potential anticancer 
properties for further studies (Russo and others 2005) 
 
The methanol extract of Sumac bran (Figure 5) had the highest percent of inhibition in 
mammary, colon and hepatic cancer cell lines (near 100%), compared to other 
samples. Sumac bran extract was the only one that inhibited all cancer cell lines. This 
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effect could be attributed to the phenolic content of the sample, especially the tannin 
content, since the methanol extract contained significant amounts of phenolics and 
tannins (Figures 1 and 4). Oxidative stress has been implicated in apoptosis and 
pathogenesis of cancers and antioxidants including proanthocyanidins can act as 
cancer chemopreventive and/or anticarcinogenic agents (Vlietnick and others 2004). 
The citotoxic effect of tannins in different cancer cell lines has been previously reported. 
Cranberries proanthocyanidins rich extracts have shown antiproliferative activity against 
the MCF-7 cancer cells (Yan 2007). Bawadi and others (2005) concluded that water-
soluble condensed black bean tannins inhibited the proliferation of Caco-2 (colon), 
MCF-7 and Hs578T (breast), and DU 145 (prostatic) cancer cells. A proanthocyanidin 
rich fraction isolated from grape seeds was used in MDA-MB468 breast carcinoma cells 
resulting in highly significant inhibition (Awargal and others 2000). Sorghums methanol 
extracts with tannin content were highly correlated with the percent inhibition in MCF-7 
cells (Table 3). 
 
In general, whole sorghum extracts had a greater inhibitory effect on mammary than on 
colon and liver cancer cell lines. Samples 1, 2, 3, 5 and 13 caused approximately 60% 
or higher inhibition on MCF-7 cancer cells (Figure 5). A similarity between the samples 
besides the antiproliferative effect in the mammary cancer cells was not found. These 
samples had no tannins (Figure 4), the anthocyanin content for samples 1, 2 and 5 was 
not significantly different from the rest of the set, samples 3 and 13 had no 
anthocyanins (Figure 3); the phenolic and flavonoid content of the samples was similar 
to other extracts (Figures 1 and 2).  These are type I sorghum samples (Table 1) except 
for sample 3 and 13 which are type II and III respectively. It is possible then, that these 
samples had a very potent type of phenolic (possibly flavonoid) exerting the inhibitory 
effect on the mammary cancer cells.   
 
The antioxidant activity of sample 3 was the lowest of the 25 sample set. This data 
suggests that antioxidant activity of the samples is not necessarily highly related to the 
in vitro antiproliferative activity. A strong correlation between ORAC values and in vitro 
citotoxicity for the mammary, colon and hepatic cancer cell lines was not found (Table 
3). Thus is possible that just a small amount of an undetermined compound has the  
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Figure 5 – In vitro citotoxic effect of sorghum extracts on different cancer cell 
lines. The characteristics of each sorghum entry tested are in Table 1. Error bars 
denote standard error. 
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potential to inhibit cancer cells by other mechanisms. The anticancer potential of 
phenolic compounds had been attributed to other mechanisms besides antioxidant 
activity, including modulation of phase 1 and phase 2 enzyme activities, anti-
inflammatory activity, induction of apoptosis, enhancement or prevention of DNA 
damage, and estrogenic and antiestrogenic activity (Stoner and Casto 2004).  
 
MCF-7 cancer cells are hormone dependent compared to Caco2 and HepG2 which are 
hormone independent cancer cells. MCF-7 cancer cells are very sensitive to estrogens 
and anti-estrogens compounds since they contain high levels of estrogen receptors 
(ER) (Coezy and others 1982).  Estrogen binds to these ER forming an estrogen-
receptor unit that begins a series of events that can instruct the cell to divide increasing 
the chance of a DNA mutation that could lead to cancer. It is possible that certain 
sorghums phytochemicals have anti-estrogen activity preventing estrogen to bind to 
ER. These compounds could be phenolics that are present in the extracts even in small 
amounts. Phenolic compounds that are known to be present in sorghum have been 
studied for their effects on hormone dependent cancers. Kaempferol significantly 
reduced the number of viable estrogen receptor-positive MCF-7 breast cancer cells 
(Nichenametla and others 2006). Green tea extracts (which are rich in catechin, 
epicatechins among others) inhibited growth of MCF-7 cells by inhibiting the interaction 
of estrogen with its receptors (Komori and others 1993). 
 
Colon cancer cells inhibition was correlated to the tannin and anthocyanin content of 
the sorghum methanol extracts (0.9635 and 0.9672); by looking at the scatter charts 
there is a tendency of an increase in cell inhibition by the increase in the content of 
these compounds, however, not all the samples with tannins and/or anthocyanins 
promote Caco2 cells citotoxicity.  
 
From the 25 sample set, just three sorghum grain extracts and the sumac bran inhibited 
liver cancer cells.  Apparently flavonoid and tannin content were also correlated with the 
inhibition of this type of cells (0.9780 and 0.9084) but there were not a significant 
number of observations to draw conclusions. A study by Liu and others (2002) reported 
26 
 
that raspberry extract rich in phenolic compounds significantly inhibited in a dose-
dependent manner the proliferation of HepG2 human liver cancer cells.  
 
There is a possibility that other non phenolic compounds present in the methanol 
extract exerted the inhibitory activity. Besides phenolics, carotenes and tocopherols, 
there have been reports of other sorghum phytochemicals like the lipid-like compounds 
present in the wax that covers the pericarp of the kernel. Studies have shown that this 
wax is high in sterols and policosanols and that these compounds have been used for 
health purposes (Hwang and others 2004; Christiansen and others 2007). Gutierrez-
Uribe and others (2008) showed that the highest anticancer activity from a type III 
sorghum extract was from a lipid-like compound. Even in very small quantities, the 
presence of these sorts of compounds on the methanol extract is possible. Sorghum 
waxes can be extracted using relatively non polar solvents (hexane, benzene, 
chloroform, acetone) because surface waxes are largely in a hydrophobically 
associated form, however small amounts of wax have been removed by just dipping 
plant leaves or whole plants in a solvent for less than 1 min,. In a study by Hwang and 
others (2002) ethanol was used for wax extraction obtaining yields similar for hexane. 
 
In summary, extract from sumac bran had the highest amount of phenolic compounds, 
flavonoids and tannins. It also exerted the highest percent of inhibition (near 100%) in 
mammary, colon and liver cancer cell lines; these results could be related to the 
phenolic content of this specific sample, specially tannin content, although other 
samples with high levels of phenols did not show the same inhibitory effect. The 
phenolic content and the ORAC values of the sorghum set were not highly correlated, 
as in previous studies. Antioxidant activity of the samples was not correlated with the 
inhibition of cancer cells. Sorghum extracts inhibited more effectively the hormone 
dependent mammary cancer cells, this effect can be related to a specific anti-estrogen 
compound. The inhibitory effect could be due to specific compounds with known 
anticancer properties such as proanthocyanidins, flavonoids (kaempferol) and phenolic 
acids (ferulic acid) or to the presence of other compounds different from the phenolics 
that could exert the anticancer effect alone or in combination with other phytochemicals 
by mechanisms different from antioxidant capacity. 
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CHAPTER III 
IN VITRO EVALUATION OF ANTICANCER PROPERTIES OF SUMAC SORGHUM 
 
Literature Review 
 
Cancer 
 
Cancer is the largest single cause of death in both men and women (Russo and others 
2005), among types of cancer, breast is a major malignancy, it affects one in every 
eight women in the USA, Europe, Australia, and Latin America; the disease kills about 
one fourth of the affected women (Bawadi and others 2005).   
 
Investigators are increasingly describing cancer as a disease that involves both 
excessive cell proliferation and inhibition of the cell´s ability to die. Cancer cells lost 
cell´s ability to undergo cell suicide by a process called apoptosis. Apoptosis is the 
mechanism by which old or damaged cells normally self-destruct (Figure 6). 
 
Cancer is ultimately the end stage of a chronic disease process characterized by 
abnormal cell and tissue differentiation: starts as an increase in the number of abnormal 
cells derived from a given normal tissue, then invasion of adjacent tissues by these 
abnormal cells, and lymphatic or blood-borne spread of malignant cells to regional 
lymph nodes and to distant sites occurs. This process which eventually leads to the 
final outcome of invasive and metastatic cancer is carcinogenesis (Sporn and Suh 
2000). 
 
Histological, epidemiological and experimental data suggest that breast carcinogenesis 
starts with hyperplasia, progressing through atypical hyperplasia to in situ and invasive 
carcinoma. The time course of these changes is difficult to estimate because, during 
this multistep process, unknown factors may stop progression and the hyperplastic 
lesions may regress and never undergo a malignant transformation (Bai and others 
2001).  
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Figure 6 – Growth control in normal and cancer cell division. Normal cells performed apoptosis while cancer 
cells have an uncontrolled growth (American Cancer Society, 2007). 
 
 
Causes of cancer include environmental (pollution, industrial), lifestyle (tobacco, diet), 
infection and genetic among others; the mechanisms are unclear: activation of 
oncogenes, loss of function of tumor suppressor genes, alteration in cell signaling 
pathways are some of the mechanisms studied. The oxidative effect of many 
compounds in cells has been studied. Cells in humans and other organisms are 
constantly exposed to a variety of oxidizing agents, some of which are necessary for 
life. These agents may be present in air, food, and water, or they may be produced by 
metabolic activity within cells. The key factor is to maintain a balance between oxidants 
and antioxidants to sustain optimal physiological conditions. Overproduction of oxidants 
can cause an imbalance, leading to oxidative stress, especially in chronic bacterial, 
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viral, and parasitic infections. Oxidative stress can cause oxidative damage to large 
biomolecules such as lipids, proteins, and DNA, resulting in an increased risk for cancer 
and cardiovascular disease (Liu 2004). This potentially cancer-inducing oxidative 
damage might be prevented or limited by dietary antioxidants (Liu 2004). 
 
Chemoprevention 
 
Chemoprevention is a pharmacological approach to intervention in order to arrest or 
reverse the process of carcinogenesis (Sporn and Suh 2000), is a preventive strategy 
used to reduce the incidence of human cancer by inhibiting the initiation and spread of 
carcinogenesis or by preventing exposure to high levels of carcinogens (Kim and others 
1999). 
 
Pharmacologic or natural agents are used to inhibit the development of invasive cancer, 
either by blocking the DNA damage that initiates carcinogenesis, or by reversing the 
progression of premalignant cells in which such damage has already occurred. The 
goal of chemoprevention can be accomplished at three different levels: (1) at the clinical 
level, development of cancer must be prevented or delayed; (2) at the tissue level, 
preinvasive or premalignant lesions must be suppressed or reversed; and (3) at the 
cellular level, atypical clones must be eradicated (Lotan and Hong 2001). 
 
Chemoprevention as a serious and practical approach to the control of cancer has been 
greatly enhanced by publication of three major randomized clinical trials in the field of 
breast cancer. Three different agents, namely tamoxifen, raloxifene and fenretinide 
have shown effective agents for prevention of breast cancer in women of varying 
degrees of risk (Sporn and Suh 2000). Incidence of breast cancer has increased in the 
last years and chemoprevention constitutes a valuable approach for its control. 
 
Many substances derived from dietary or medicinal plants are known to be effective and 
versatile chemopreventive and antitumoral agents in a number of experimental models 
of carcinogenesis. Among the many classes of plant chemicals studied, phenolic 
compounds have been identified as anticancer agents and are consumed by humans in 
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a variety of plant foods and beverages (Singletary and others 2003). Hirose and others 
(1994) found that green tea catechins (GTC) in particular, inhibit rat mammary gland 
carcinogenesis. Purdue Research Foundation (2002) presented a US patent related to 
tea catechins as cancer specific proliferation inhibitors. Singletary and others (2003) 
studied the effects of concord grape juice, concluding that can inhibit the promotion 
stage of (DMBA)-induced rat mammary tumorigenesis in part by suppresing cell 
proliferation. The potential health enhancing properties of condensed tannins from black 
beans as inhibitors of angiogenesis was discussed by Bawadi and others (2005). 
Seeram and others (2005), studied polyphenols found in pomegranate juice for in vitro 
antiproliferative, apoptotic and antioxidant activities. Ademawobo and others (2005) 
hypothesized that flavonols reduce the risk of breast cancer through their effects on 
several biochemical pathways involved in carcinogenesis.  
 
There have been numerous mechanisms by which plant phenolics, are hypothesized to 
be acting, including suppression of cellular oxidation, modulation of mitogenic signaling, 
suppression of aromatase activity, inhibition of inflammatory processes and 
angiogenesis, and induction of apoptosis (Singletary and others 2003). 
 
In vitro studies 
 
For the screening of potential chemopreventive agents, in vitro short-term tests can be 
applied because they are less time consuming, and also inexpensive and simple. In 
vitro tests can serve as biomarkers or endpoints of cancer to provide valuable insights 
into the mechanisms underlying carcinogenic processes and help screen for new 
chemopreventive agents (Kim and others 1999). 
 
Cell lines are widely used in many aspects of laboratory research and particularly as in 
vitro models in cancer research (Burdall and others 2003). Techniques required to allow 
cells to grow and be maintained outside the body have been developed throughout the 
20th century. Although some caution is required in interpreting data obtained by 
studying cells in vitro, it has allowed investigation of a complex disease such as cancer 
to be simplified to its component parts.  
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Citotoxic assays 
 
Much effort has been made in the search for cancer chemopreventive agents and in 
vitro short-term tests are a valuable tool in the process. By using bioassays, fractions of 
active compounds can be tested in a specific cell line, to evaluate whether or not they 
possess a citotoxic effect.  
 
The majority of breast cancer research uses established mammary cancer cell lines as 
in vitro models. MCF-7 is a breast cancer cell line derived in the Michigan Cancer 
Foundation in 1973 from a pleural effusion and is the most commonly used cancer cell 
line worldwide (Burdall and others 2003).  
 
The human intestinal Caco-2 cell line has been also extensively used over the last 
twenty years as a model of the intestinal barrier. Caco-2 cells were derived from a 
human colon adenocarcinoma, and they differentiate spontaneously in vitro under 
standard culture conditions thereby exhibiting, enterocyte-like structural and functional 
characteristics. In differentiated state, they mimic typical characteristics of the human 
small intestinal epithelium, like a well-developed brush border with associated enzymes 
such as alkaline phosphatase and sucrase isomaltase (Lenaerts and others 2007). 
 
The cell line HepG2 is derived from a well differentiated human hepatoblastoma, which 
retains many of the morphological characteristics of liver parenchymal cells. The ability 
to measure mutagenicity and genotoxicity directly in a single cell line of human origin 
and epithelial cell type, combined with the capacity for metabolic activation and 
proliferation makes the HepG2 cell line relevant as a model system for short-term 
testing of human mutagens and carcinogens (Eddy and others 1987) 
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Materials and Methods 
 
Sample extraction for in vitro analysis 
 
Sumac bran and whole sumac sorghum were extracted with aqueous methanol (80%). 
Solvent (100 ml) was added to 10 g of finely ground sample in 250 ml Erlenmeyer flask 
and placed in the shaker for 3 h at 150 rpm at 25°C for extraction. Sample was then 
filtered through Whatman 1 filter paper in a Buchner funnel under vacuum. Solids were 
resuspended twice in fresh solvent and extraction was repeated. Filtrate (100 ml from 
each extraction) was concentrated using a rotary evaporator set at 40°C to near 
dryness. Sample was resuspended with distilled water, sonicated and then lyophilized 
with a Freezemobile FM25EL-85 (SP Industries, Germany). Dry samples were weighed 
and labeled as crude extracts. 
 
A sample of tannin extracted bran was prepared by diluting 2 g of crude extract from 
sumac bran in 10 ml of water, the solution was then homogenized and passed through 
a C18 Sep-pack column, then methanol was passed through the column and the eluent 
passed through a NH2 column, tannins were retained and the eluent lyophilized and 
labeled, and saved for further analysis.  
 
In vitro analysis 
 
Cells were cultured as described by Romo-Lopez (2005). Cell viability was estimated by 
trypan blue exclusion test. A 100 µl Cells (1 x 105 cell/ml) were injected in a 96-well 
plate, maintained in Dulbecco´s modified Eagle´s medium (DMEM) containing 10% fetal 
calf serum (FCS) and 100 U/ml penicillin, and 100µg/ml streptomycin. After 24 h 
incubation at 37ºC under a humidified 5% carbon dioxide atmosphere to allow cell 
attachment, cells were treated with sumac extract and incubated for 72 h under the 
same conditions. 
 
Extract was used to measure the ability of sumac bran to inhibit cancer cell proliferation. 
Cell cultures were exposed to 0.06, 0.125, 0.25 and 0.5 mg/ml concentration of the 
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extract. Cell proliferation was measured using the CellTiter 96® AQueous One Solution 
Cell Proliferation (Promega Corporation, Madison, WI) colorimetric based assay. Cell 
proliferation was measured by the ability of viable cells to reduce 3-(4,5-dimethylthiazol-
2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfenyl)-2H-tetrazolium (MTS) to formazan. The 
absorbance at 490nm was measured using a SynergyTM HT Multi-Detection microplate 
reader (Bio-Tek Instruments, Inc., Winooski, VT). The concentration inhibiting 50% 
growth (IC50) was determined and expressed as milligrams of extract per milliliter. 
 
Statistical analysis 
 
Results are means of 2 replications, 3 determinations per replicate ± standard error. 
Data were analyzed using a Microsoft Excel (Microsoft, Redmon WA) spreadsheet. 
 
 
Results and Discussion 
 
Screening of different types of sumac sorghum extracts was performed to identify the 
one with the highest citotoxicity against cancer cell lines. Extracts of sumac whole grain, 
sumac bran with and without tannins were compared. 
 
When tested on MCF-7 cells, methanol extract from sumac bran had higher percent 
inhibition compared to extracts obtained from whole grain, and the tannin free bran 
extract (Figure 7). As concentration of the extract increased, percent inhibition 
increased; at 0.50 mg/ml 100% inhibition was obtained. The whole sorghum extract did 
not show good inhibition, maximum inhibition obtained was near 5%, this may be due to 
a dilution effect of the active compounds present in the bran or to the presence of other 
compounds that inhibited or reduced the citotoxic effect. 
 
When the tannins were removed the inhibition was significantly reduced, with maximum 
inhibition at 40%. Thus tannins play an important part of the citotoxic effect of the 
sumac methanol extract, either by themselves or acting synergistically with other 
compounds present in the extract. 
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Figure 7 – Citotoxicity curves of different sumac sorghum extracts on MCF-7 
cancer cells. Each point value is the average of two determinations. 
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When extracts were tested on liver cancer cells, the sumac bran extract also showed 
the highest percent of inhibition (100%) while the tannin free bran and whole sorghum 
extracts had 70 and 60% inhibition respectively (Figure 8). In this case whole sorghum 
and detannified extracts were almost as effective against HepG2 cells. In all cases as 
concentration of extracts increased the percent inhibition increased. Even though this is 
a different type of cancer cell line (non-hormone dependent) the phytochemicals 
associated to the sorghum bran extract exerted a similar inhibitory trend compared with 
the  MCF-7 cells in vitro assay, the crude bran extract inhibited cancer cell growth more 
efficiently than the tannin free bran extract and the whole sorghum extract respectively. 
As concentration of extracts increased, the percent inhibition of colon cancer cells 
increased (Figure 9). The whole sumac grain extract exhibited the highest percent of 
inhibition (almost 100%) at a concentration of 0.5 mg/ml in Caco2 cancer cells. Bran 
and tannin free bran extracts also had good inhibition at high concentrations (above 
70%). It appears that in colon cancer cells the component that promotes cells death is 
present regardless of the material used for extraction and in an amount sufficient to 
inhibit cancer cells; these compounds could be condensed tannins. 
 
From these results (Figures 7 and 8) it was evident that tannins had an important role in 
the citotoxic effect of the extracts against MCF-7 breast and HepG2 liver cancer cells. 
In the last years studies have been performed in where polyphenols (proanthocyanidins 
– tannins) from food sources different from sorghum such as wine and grape seeds 
have been tested for anticancer properties. The degree of polymerization of the tannins 
and how they absorbed in the body would affect the anticancer properties of these 
compounds in in vivo studies.  
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Figure 8 – Citotoxicity curves of different sumac sorghum extracts on liver 
HepG2 cancer cells. Each point value is the average of two determinations. 
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Figure 9 – Citotoxicity curves of different sumac sorghum extracts on Caco2 
cancer cells. Each point value is the average of two determinations. 
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Tannins (proanthocyanidins) in sorghum are mainly B-type homopolymers of 
catechin/epicatechin. A-type proanthocyanidinds where the flavan-3-ol units are linked 
by C4-C8 interflavan bonds and by additional ether bond between C2-C7 have also 
been identified. A- and B- type heteropolymers with both catechin/epicatechin and 
gallocatechin/epigallocatechin hydroxylation patterns and glucosylated 
heteropolyflavans with proluteolinidin or proapigeninidin as extension units and the 
flavonones eriodictyyol or eriodictyol 5-O- glucoside as terminal units have been 
reported (Dykes and Rooney 2006 ; Krueger and others 2003).   
 
In a recent study, extracts from red wine containing mainly B-type proanthocyanidin 
dimmers were tested in vitro and in vivo, it was demonstrated they could suppress 
estrogen biosynthesis, therefore could be used as chemopreventive agents against 
breast cancer (Eng and others 2003). Grape seed extracts containing dimmers, trimers 
and other oligomers of flavan-3-ols were tested against MDA-MB468 breast cancer 
cells resulting in a significant growth inhibition (Agarwal and others 2000). 
 
Tannins have shown to act as anti-initiators or antipromotores of cancer. A grape seed 
polyphenol extract (5, 10 and 20 mg) resulted in 30, 40 and 60% inhibition of skin tumor 
incidence in DMBA-initiated mouse skin. In addition, the number of tumors per mouse 
decreased by 63%, 51%, and 94% (Stoner and Casto 2004). The basic components of 
tannins (catechins, epicatechins, gallocatechins, epigallocatechins) have been related 
to cancer preventive properties. Several in vitro studies have shown that catechins and 
other structurally related compounds exhibited antiproliferative and growth controlling 
properties in cancerous and normal cell lines. Epigallocatechin and gallocatechin have 
been shown to exhibit antiproliferative action against MCF-7 breast cancer cells 
(Niechenametla and others 2006).  
 
In summary, the methanol extract from sumac bran had the highest percent inhibition in 
all three types of cancer cell lines, especially against the hormone dependent mammary 
cancer cells (MCF-7). The major effect of the extract could be attributed to the tannin 
content. This extract was selected, and citotoxic bioassays were performed at different 
concentrations to determine doses to be used in an in vivo rat study.  
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Figure 10 – Evaluation of sumac bran extract on MCF-7 mammary cancer cells. 
Results are means of three replicates (four determinations per replicate). Error 
bars denote standard error. 
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The anticancer effect of sumac bran extract was evaluated in MCF-7 cancer cells at 
different concentrations. As the concentration of the extract increased, antiproliferative 
effects increased (Figure 10). Almost 100% inhibition was obtained when using a 
concentration of 0.5 mg/ml. An IC50 value of 0.189 mg/ml was calculated from the 
curve; the curve shape was similar to the one observed in the screening part.  
 
Growth inhibitory potency of different compounds in breast cancer cells have been 
reported in the literature. Genistein which is an isoflavone with chemopreventive 
properties has IC50 reported values of 0.0065 to 0.0105 mg/ml for (Peterson 1995). The 
effective concentration of catechins to exert in vitro antiproliferative activity seems to be 
0.005mg/ml to 0.03mg/ml based on the type of cells (Nichenametla 2006). The IC50 for 
the inhibition of proliferation of MCF-7 by -tocopherol was reported as 0.125mg/ml 
(Guthrie and others 1997).  Compared to these data, the IC50 value of 0.189 mg/ml 
calculated for the methanol extract of sumac bran can be considered low, because this 
is a crude extract and not an isolated fraction or compound. The IC50 for MCF-7 cells 
was smaller than values for liver and colon cell lines. Therefore, the methanol sumac 
bran extract had a more potent effect on the hormone dependent cancer cells. The 
inhibitory effect of this extract could be due to a specific phenolic or a combination of 
phenolic components. From previous results it appeared that tannins had an important 
role in the observed citotoxic effect.  
 
Other phenolic components present in sorghum like hydroxicinnamic acids (ferulic, 
caffeic, p-coumaric) and hydroxybenzoic acids (gallic, protocatechuic, vanillic) (Dykes 
and Rooney 2006), have been obtained from different fruits and have been reported to 
possess anticancer properties. Research was conducted with blackberries, raspberries, 
lemons and oranges, among other fruits. An extract containing p-coumaric, caffeic, 
ferulic, sinapic, and methoxycinnaic acids in combination with p-coumaric and vanillic 
acids inhibited viability and the colony-forming capacity of human breast and colon 
cancer cells in vitro. Ferulic acid added to diet on male rats significantly reduced the 
frequency of tongue carcinomas, and was proposed as an effective agent for oral 
cancer chemoprevention (Stoner and Casto 2004). 
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Figure 11 – Evaluation of anticancer effect of sumac bran extract on Caco2 colon 
cancer cells. Results are average of three replicates (four determinations per 
replicate). Error bars denote standard error.  
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Figure 12 – Evaluation of anticancer potential of sumac bran extract on HepG 2, 
liver cancer cells. Error bars denote standard error. 
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When tested against colon cancer cells, as the concentration of the methanol extract 
from sumac bran increased, percent inhibition of cells also increased. In this case, a 
100% inhibition could not be reached; almost 75% inhibition was obtained at 0.5mg/ml 
concentration (Figure 11). These results were consistent with the ones observed in the 
screening part, where maximum inhibition was around 85%. Differences in percent 
inhibition among cell lines are due to the nature of the cancer cells, MCF-7 cells are 
hormone dependant, Caco2 cells are not. IC50 value obtained from the curve was of 
0.286 mg/ml. This is a low value taking into account that we tested and extract and not 
a fraction of a specific compound. These results are consistent with different in vitro 
studies. A blueberry extract rich in tannins and flavonoids tested in Caco2 cells had an 
IC50 value of 0.1 mg/ml. A grape seed extract rich in proanthocyanidins was tested on 
human colorectal HT29 and LoVo cancer cells; concentrations of 0.1mg/ml inhibited 
near 40 and 60% of the HT29 and LoVo cells respectively (Kaur and others 2006). In 
the case of isolated compounds, like the flavones apigenin and luteolin reported to be 
present in sorghum, IC50 values of 0.025 and 0.031 mg/ml respectively when used in 
Caco2 colon cancer cells, were reported by Kuntz and others (1999), the effect was 
associated with induction of the apoptotic pathway of cells. Results of the inhibitory 
effect of the methanol sumac bran extract also are consistent with an in vivo colon 
cancer study were brown and black sorghum brans administered in the diet reduced 
colon carcinogenesis in rats (Turner and others 2006). 
 
For HepG 2 cells, a maximum percent inhibition of 95 was reached at a concentration of 
0.5 mg/ml. IC50 value for HepG 2 cells was 0.26 mg/ml (Figure 12). When extracts from 
different raspberries varieties were tested in HepG2 cancer cells, IC50 antiproliferative 
values of  15 to 30 mg/ml were reported (Liu and others 2002). Compared to these 
values sumac bran methanol extract is a more potent antiproliferative agent compared 
to raspberries.  
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In summary, methanol extract from sumac bran had good inhibition potency against the 
three cancer cell lines, especially against the hormone dependent breast cancer cells 
MCF-7. Extract at a concentration of 0.5mg/ml inhibited 100% mammary cancer cells. 
The effect of the extract could be attributed at least in part to the tannin content. This 
concentration was selected in order to determine bran and extract concentrations for 
the DMBA induced rat in vivo study. 
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CHAPTER IV 
IN VIVO EVALUATION OF SUMAC SORGHUM USING DMBA INDUCED FEMALE 
RATS 
 
Literature Review 
 
Sorghum and health 
 
Several health and pharmaceutical benefits of sorghum have been reported recently 
(Dykes and others 2005). Compounds studied include protein fractions, sterols and 
policosanols and different sorts of phenolic compounds; these compounds have been 
related to health benefits such as cholesterol lowering properties and positive effects on 
cancer among others.  
 
In a study of Kamath and others (2005) the  kafirin of sorghum was treated with 
chymotrypsin and separated yielding four different fractions that showed to possess 
angiotensin I converting enzyme inhibitory activity. Angiotensin I by itself is inactive, but 
when converted by the angiotensin-converting enzyme (ACE) to angiotensin II (active 
form), it causes narrowing of small blood vessels resulting in an increase in blood 
pressure. 
 
Sorghum sterols and policosanols recently have been studied for its anti-
cholesterolemic effects. A lipid extract from sorghum kernel tested on male hamsters 
significantly reduced plasma non HDL-cholesterol concentrations; sterols and 
policosanols were detected in the extract in concentrations of 0.35 and 8.0 g/100g of 
extract, respectively. Authors suggested that sterols reduced cholesterol absorption 
while policosanols inhibited endogenous cholesterol synthesis (Carr and others 2005). 
In other study by Burdette and others (2007), a sorghum fraction was reported to have 
a preventive effect on plasma lipids in the hyperlipidemic Syrian hamster model.   

The anti-inflammatory effects of sorghum phenolic extracts in a topical inflammatory 
animal model were studied by Burdette and others (2007), extracts of sumac and black 
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sorghum brans had anti-inflammatory effects statistically similar to that produced by 
indomethacin (a non steroidal anti-inflammatory drug).  
 
The chemopreventive properties of procyanidins from different fruits and vegetables 
have been widely studied with positive results (Stoner and Casto 2004). Bran from 
certain sorghums is a rich source of this type of phenolic compounds, commonly 
referred as tannins. Turner and others (2006) showed that induced rats fed with black 
and tanning sorghum bran had fewer aberrant colon crypts than those fed diets 
containing cellulose or white sorghum bran. Since tannins are very large molecules they 
are not absorbed intact. Recent studies have demonstrated that monomers and 3-mers 
are the major forms of procyanidins absorbed (Prior and others 2007). Awika and 
others (2004) discussed the positive effects of sorghum consumption on cancer, they 
suggested sorghum contains anticarcinogenic compounds, and that additional in vitro 
and in vivo studies are necessary to understand how polyphenols in sorghum affect 
cancer.  
 
In vivo studies 
 
Animal models of breast cancer have been widely used to study various aspects of 
breast cancer biology. The two most widely used experimental systems for the study of 
rat mammary tumorgenesis are the models in which tumors are induced in Sprague-
Dawley (S-D) rat by 7,12-dymethylbenz(a)-anthracene (DMBA) or in the S-D or Fischer 
344 rat by N-methylnitrosourea (NMU) (Russo and Russo 1996). DMBA is a synthetic 
polycyclic aromatic hydrocarbon that has been used extensively as a prototype agent in 
mutation and cancer research (Izzotti and others 1999) 
 
Chemically induced mammary tumors develop by a multistep process. The initial step is 
a biochemical lesion caused by the interaction of the carcinogen with cellular DNA. In 
this interaction the DNA is damaged, and if the damage is not repaired efficiently, the 
result is a mutation, chromosomal translocation, inactivation of regulatory genes or 
more subtle changes not well identified as yet. Neoplastic development requires that 
the lesion becomes fixed, aided by cell proliferation, progressing to a third stage of 
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autonomous growth, resulting in cancer, when the lesion acquires the capacity to 
invade and metastasize (Russo and Russo 2004) 
 
DMBA given by gavage in a single dose of 2.5 to 20 mg, induces tumors with latencies 
that generally range between 8 and 21 weeks with final tumor incidences close to 100% 
if sufficient time elapses before necropsy (Russo and Russo 1996). The susceptibility of 
the mammary gland to DMBA or NMU induced carcinogenesis is strongly age-
dependent, and is a maximal when the carcinogens are administered to animals 
between the ages of approximately 45 and 60 days, that is the age of sexual maturity. 
(Russo and Russo 1996) Mammary tumors induced are hormone-dependent 
adenocarcinomas arising from terminal end buds (TEBs) on incompletely differentiated 
glands. These tumors bear a close resemblance to human breast cancer in their 
histologic and hormone-response patterns (Dias and others 2000). 
 
The DMBA rat mammary model has found a broad application as a tool for assessing 
the efficacy of chemopreventive agents in inhibiting the formation of mammary tumors 
in preclinical studies (Izzotti and others 1999) The susceptibility of the mammary gland 
to carcinogenesis is modulated by the following parameters: 1) the presence of terminal 
end buds; 2) the size of the proliferative compartment; 3) the amount of binding of the 
carcinogen to the DNA; and 4) the ability of the cells to repair the DNA damaged by the 
carcinogen (Russo and Russo 1996) 
 
The model has been widely used to assess the preventive cancer properties in different 
studies. Many popular dietary supplements enriched in polyphenols such as soy 
isoflavones, tea catechins, and resveratrol, have shown chemopreventive activity in 
cellular models of cancer. The health effects of green tea catechins in in vivo animal 
models were reviewed by Crespy and Williamson (2004), they concluded that studies 
using animal models showed that green tea catechins provided some protection against 
degenerative diseases, could act as antitumorigenic agents and could act as preventive 
agents against mammary cancer postinitiation. 
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Materials and Methods 
 
A preventive mammary cancer study was conducted with laboratory rats. Four different 
treatments and a control were included (Table 4). Treatments were selected from the 
first two sections of the research by evaluating the anticancer potential of the samples 
in vitro. Treatments included sumac bran extract at 0.5 and 1.5 mg/ml concentration 
and the correspondent amount of bran. Extract concentrations were the ones that had 
100% in vitro MCF-7 inhibition and 3X that amount, respectively.  
 
 
Table 4 - Treatments selected to test the preventive effect of sumac bran and 80% 
methanol extracts using DMBA induced female rats 
 
Identification Treatment* 
Control No extract or bran added. Negative control. 
Low extract 0.5 mg/ml of sumac bran extract, equivalent to 0.05% of diet 
High extract 1.5 mg/ml of sumac bran extract, equivalent to 0.15% of diet 
Low bran 40 mg of sumac bran, amount necessary to obtain 0.5mg of extract, 
equivalent to 0.4% of diet 
High bran 120mg of sumac bran, amount necessary to obtain 0.5mg of extract, 
equivalent to 1.2% of diet. 
*The bran concentration was determined considering a 12.5% yield of bran to extract. The extract concentration was 
determined considering 10ml of serum/rat, 10gr of diet/day/rat. DMBA 10mg/kg of body weight. 
 
 
Extracts for in vivo study were obtained as described in the section of in vitro evaluation 
of anticancer properties of sumac sorghum, (sample extraction for in vitro analysis). In 
this case extractions were performed using 80 g of finely ground bran placed in a 1000 
ml Erlenmeyer flask with 800 ml of aqueous methanol. 
 
A total of 105 Wistar female rats (20-23 rats per treatment), 36-d-old weighing 75-100 g, 
were acclimated to the facility. Rats were blocked according to initial body weight. Then 
animals were randomly assigned to treatments and divided into groups of 4-6 in 
stainless steel cages and placed in a constant temperature and lighting environment 
(Table 5).  
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Table 5 - Distribution of rats per treatment for the in vivo experiment* 
Treatment High Medium Low Super low Rats/treatment 
Control 5 5 5 8 23 
Low extract 5 5 5 6 21 
High extract 5 5 5 6 21 
Low bran 5 5 5 5 20 
High bran 5 5 5 5 20 
Total    n= 105 
 *Initial number of rats per treatment, some rats died during experiment. 
 
 
Rats had free access to diet and water. Beginning at 36-d-old (a week before DMBA 
induction) until the end of the experiment sorghum treatments were administered in the 
diet. Diets were formulated isocaloric, isonitrogenous, isolipidic and isofibrous (Table 6). 
Bran was analyzed to make proper adjustments (proteins 12.46%, lipids 7.61% and 
crude fiber 6.31%). Pellets were made to deliver diet-treatment to rats. A pelletizer 
(cellulose base) was included in the formula to enhance pellet formation (0.15%). Dry 
ingredients were mixed in a Hobart mixer at 1 speed for 2.5 min. Then, water was 
added (40%) and mixing continued for 1 min approximately. The dough like material 
was immediately formed into a “cylinder” and cut in approximately 1.5 cm width pellets. 
Pieces were placed in baking sheets and put into a convection oven set at 50-55°C for 
16 – 20 h. Dry pellets were placed in plastic bags and frozen until used. 
 
At 50-d-old a single intra-gastric dose of 10 mg/kg body weight of DMBA suspended in 
corn oil was administered to rats. Mammary tumor development was evaluated weekly, 
beginning at 5 weeks after DMBA administration. Time of appearance, location, number 
and size of tumors were documented during the experiment. At 20 weeks after DMBA 
administration rats were weighed, anesthetized, and tumors were excised according to 
the procedures of Appelt and Reicks (1999) and Zavala (2005). 
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Table 6 - Diet formulation per treatment for the in vivo study conducted with 
DMBA induced rats* 
 
 Control Low 
Extract 
High 
Extract 
Low 
Bran 
High 
Bran 
INGREDIENTS % % % % % 
Starch 50 49.95 49.85 49.72 49.15 
Casein 20 20 20 19.94 19.82 
Sugar 15.2 15.2 15.2 15.2 15.2 
Vegetable oil 5 5 5 4.97 4.91 
Cellulose 5 5 5 4.97 4.92 
Mineral mix 3.5 3.5 3.5 3.5 3.5 
Vitamin mix 1 1 1 1 1 
DL-Methionine 0.3 0.3 0.3 0.3 0.3 
Bran - - - 0.4 1.2 
Crude extract - 0.05 0.15 - - 
TOTAL 100 100 100 100 100 
*Starch (corn starch), casein  (casein purified high nitrogen MP Biomedicals), sugar (brown sugar economax), vegetable 
oil (soy + canola oil, economax), cellulose (alphacel non-nutritive bulk MP Biomedicals), mineral mix (ain-76 mineral 
mixture MP Biomedicals), vitamin mix (ain vitamin mixture 76, MP Biomedicals), DL-methionine. 
 
 
 
Results and Discussion 
 
An in vivo study with female rats was conducted. Bran and methanol extract from 
sumac bran were tested for anticancer potential; these treatments were selected from 
the experiments performed in the “screening and characterization of different sorghum 
for anticancer potential” and the “in vitro evaluation of anticancer properties of sumac 
sorghum” sections. Sumac bran was selected from the 25 sample set and the methanol 
extract after analyzing data of the MCF-7 in vitro assays.   
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Table 7 – Rats distribution for in vivo study* 
Treatment High 
Weight 
Medium 
Weight 
Medium-
Low Weight 
Low Weight Rats/treatment 
Control 4 2 5 7 18 
Low extract 5 2 5 6 18 
High extract 2 3 5 6 16 
Low bran 5 3 5 5 18 
High bran 3 2 4 5 14 
Total    n= 105 
 * Rats per treatment at the end of the experiment.  
 
At the beginning of the experiment 105 rats were assigned to four different treatments 
or a control group and at least 20 rats were on each of the treatments. During the 
experiment rats from the first two blocks (high and medium weight) got sick and some 
died, 25 and 50% respectively (Table 7). Rats from the high and medium blocks did not 
gain weight as compared to medium-low and low blocks (Figure 13). While rats from the 
medium-low and low blocks at the end of the experiment weighed over 350 g; some of 
high and medium block rats did not reach 200g. For these reasons the first two blocks 
were eliminated from the in vivo results. 
 
Figure 13 shows the differences in weekly weight gains of the rats assigned to the 
different blocks. At the beginning of the experiment animals weighed an average of 
100g, differences between blocks was significant at week 10 until the end of the study. 
Rats belonging to the high-weight block were thin and did not gain enough weight 
during the experiment. Rats belonging to the medium-weight block were also 
underweight, with reduced weight gain compared to the other two blocks.  
 
Differences in weekly-weight gains among treatments (diets) were not evident 
throughout the experiment (Figure 14) indicating that blocking by initial body weight 
reduced the experimental error. Average weight of rats belonging to control, low extract, 
high extract, low bran and high bran groups were very similar during the 20 weeks of 
the experiment. Figure 13 shows large body weight differences according to block and 
Figure 14 clearly demonstrates the different dietary treatments did not affect body 
weights throughout the 20 weeks of the experiment.   
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Figure 13 – Average weight of rats by block during the 20 week study. 
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Figure 14 – Average weight of rats by treatment during the 20 week study. 
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Figure 15 – Cumulative tumor incidence by treatments. Rats from blocks with 
medium–low and low initial body weight. 
 
 
 
 
-10.00
0.00
10.00
20.00
30.00
40.00
50.00
60.00
70.00
80.00
90.00
5 10 15 20
%
 
Tu
m
o
r 
in
ci
de
n
ce
Weeks after DMBA administration
Control
Low extract
High extract
Low bran
High bran
55 
 
 
The percent tumor incidence during and at the end of the experiment was recorded for 
the four treatments and the control group (Figure 15). Surprisingly rats fed with the low 
extract diet had the highest percent of tumor incidence (80%). Fifty percent and 45% of 
the animals fed the control and high extract developed tumors while counterparts fed 
the high and low bran had 33 and 30% tumor incidence respectively.  
 
Differences among treatments were not statistically different at any point. However a 
P‹0.10 indicate that differences in tumor incidence between rats fed with extract and 
rats fed with bran were evident. Figure 15 clearly shows that animals fed the sorghum 
bran treatments had the lowest tumor incidence. Unexpectedly animals on the low 
methanol extract diets had more tumors than the rest of the treatments including the 
control. Probably during the process of extraction an estrogenic compound was 
concentrated, which promoted tumors at the concentration used in the diet (0.05%). 
The tumor incidence of animals fed the high extract diet was similar to the control group 
and lower compared to rats fed the low extract diet. The difference can be attributed to 
estrogenic compounds which according to concentration can exert or inhibit the 
development of hormone dependent tumors. Estrogen influences the growth, 
differentiation and function of many target tissues including the mammary gland. 
Estrogen is retained in certain target cells (such as the cells of the breast tissue) by the 
estrogen receptor. Estrogen receptors exist as subtypes  and .  Phytoestrogens 
(weakly estrogenic compounds) are believed to exert their chemopreventive action by 
interacting with estrogen receptors (ER) (Kuiper and others 1998), they prevent 
estrogen to form an estrogen-receptor unit that can instruct the cell to divide increasing 
the chance of a DNA mutation that could lead to cancer. Phytoestrogens however, 
depending on the concentration (may be present at high concentrations compared to 
that of endogenous estrogen) and the affinity to  or  receptor, can exert the 
prevention or promotion of cell division. It has been demonstrated that extracts with 
phytoestrogens had the ability to bind preferentially to ER stimulating the transcription 
of genes regulated by ER resulting in the induction of estrogen-dependent cancer cell 
growth (Boué and others 2003). Kaempferol for example, can act as an estrogen 
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receptor agonist (low concentrations) or growth inhibitor depending on concentrations 
used (Nichenametla and others 2006) 
 
Both sorghum bran treatments had an inhibitory effect at high and low concentrations, 
compared to their methanol extracts and control group. Results of the inhibitory effect of 
the methanol sumac bran extract are consistent with an in vivo colon cancer study were 
brown and black sorghum brans administered in the diet reduced colon carcinogenesis 
in rats (Turner and others 2006). 
 
The preventive effect could be attributed to the phenolic or to a different type of 
compounds. When preparing the extract, certain compounds in the bran were diluted in 
the methanol; other compounds were not extracted and remained in the insoluble mass 
that was discarded after extraction. From the in vivo data it appeared that bran contains 
compounds not obtained in the extract that had an inhibitory effect on tumors, these 
could be non-polar compounds such as the ones present in the sorghum wax 
(phytoesterols, policosanols) that could be acting alone or more probably together with 
other compounds as cancer preventive substances.  Epidemiologic and experimental 
studies have suggested that dietary phytosterols may offer protection from common 
cancers such as colon, breast and prostate (Awad and Fink, 2000). Gutierrez-Uribe and 
others (2008) reported that a compound different from flavonoids with a molecular 
formula of C17H30O3 or C18H34O2 isolated from a type III sorghum had anticancer 
properties.  
 
It appeared that bran treatments worked at the beginning of the carcinogenesis process 
in some of the animals. DMBA induced tumors develops by a multistep process. The 
initial step is a lesion caused by the interaction of the carcinogen with cellular DNA 
resulting in a promutagenic lesion (DNA adducts). Unless efficiently removed DNA 
adducts turns into tumors (Izzotti and others 1999). One of the possible mechanisms of 
cancer prevention in the bran treatment could be the prevention of adduct formation by 
the phenolic content of the sample. Phenolic compounds can enhance detoxification of 
carcinogens and decrease DNA damage (Jung and others 2006). Phenolics in purple 
grape juice (including proanthocyanidins) blocked the initiation stage of DMBA induced 
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rat tumors by suppressing mammary DMBA-DNA adduct formation, in part by an 
increase in the phase II enzyme metabolism (Jung and others 2006). Other phenolics 
like ferulic acid have been reported to deactivate carcinogens (Nichenametla and others 
2006) 
 
During evaluation of tumor(s) formation by palpation it was noticed that four rats 
belonging to the high and low bran concentrations diets had palpable follicle tumors that 
disappeared approximately 2 weeks afterwards. If tumors do not have enough blood to 
keep growing (vascularization) they could shrink and eventually disappear. This critical 
process in cancer biology is commonly known as angiogenesis. Some of the bran 
compounds may have inhibited tumor growth in these animals.  Bran tannins could be 
the compounds acting as suppressing cancer agents, inhibiting blood vessel formation 
or angiogenesis. VEGF (vascular endothelial growth factor) has been shown to have an 
important role in the regulation of angiogenesis and water soluble condensed tannins 
from black bean inhibited the proliferation of cancer cells through inhibition of 
angiogenic factors such as VEGF (Bawadi and others 2005). 
 
 
Table 8 - Tumor incidence, latency period, tumor/tumor-bearing rat and tumor 
weight in rats treated with DMBA1 
 
Diet n Tumor incidence Tumor latency 
period 
Tumors/Tumor 
bearing rat 
Tumor 
weight 
  % wk  g 
Control 12 50.00 11.3±1.4 1.5±0.16 6.92±2.1 
Low extract 11 81.82 13.3±0.8 1.6±0.22 6.89±1.4 
High extract 11 45.45 11.8±1.3 1.2±0.13 3.20±0.5 
Low bran 10 30.00 10.7±1.3 1.7±0.18 5.33±1.3 
High bran 9 33.33 10.7±1.7 1.7±0.19 5.07±1.6 
1 Values for tumor latent period, number of tumors/tumor-bearing rat, and tumor weight are means ±SEM. Tumor 
incidence was measured at the termination of the experiment (20 wk). Values are for palpable and non palpable tumors 
discovered upon termination of the experiment. None of the values are significantly different.   
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Tumor per rat, tumor weight, and tumor latency period were not statistically different 
among treatments (Table 8). The tumor latency period post DMBA administration was 
around week 10 for animals fed bran treatments and week 11 for control and high 
extract diets. Tumor latency of the low extract treatment was around week 13; even 
though it took longer for the tumors to appear, this treatment had the higher incidence 
of tumors.  
 
Tumors per rat were between 1 and 2 in all cases. Bran treatments had the higher 
number of tumors per rats, although treatments with bran had the lowest incidence. 
Tumor bearing rats had in most cases 2 neoplasias. Control and low extract groups had 
higher tumor weight than the rest of the groups; tumors of rats were in some cases 10% 
of the live weight of the animal. Low extract compounds promoted growth of tumors. 
Tumors of rats on high extract diet were smaller than the other groups.  
 
Results from the in vivo study were not as expected, because the in vitro data clearly 
suggested that the methanol extracts at different dosages had an inhibitory effect on 
hormone dependent and regular cancer cells.  The in vivo study did not support results 
because rats fed the methanol extracts, especially the low concentration extract diet, 
had more tumors compared to the other treatments. One of the reasons for this is that 
for the in vitro studies, compounds (extracts) were directly put in contact with the cancer 
cells; in the animal study, compounds were delivered through the diet and were 
probably not completely absorbed and even when absorbed, they could be metabolized 
or modified in different ways. According to Manach and others (2004), polyphenols are 
not necessarily very active within the body either because they have a lower intrinsic 
activity or because they are poorly absorbed from the intestine, highly metabolized, or 
rapidly eliminated. In addition metabolites found in blood and target organs from 
digestive or hepatic activity may differ from the native substances in terms of biological 
activity. 
 
In the previous experiments tannins appeared to be responsible (at least in some part) 
for the inhibitory effect of the methanol extract on the cancer cell lines. Tannins are 
large molecules containing multiple subunits from 1 to over 100 (Prior and others 2007). 
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Different studies have demonstrated that tannin bioavailability is low, and that it need to 
be depolymerized to be absorbed.  Gu and others (2004) reported that in pigs 
proanthocyanidins were stable in the stomach and small intestine but depolymerized 
and degraded rapidly in the cecum and large intestine by bacteria. Prior and others 
(2007) conclude that the major form of tannin absorption was in molecules possessing 
1 to 3 subunits.  In a recent study by Gu and others (2007) sorghum bran was fed to 
piglets via gastric gavage. Sorghum bran had 44 mg/g of procyanidins. More than 80% 
were polymers with more than 10 catechin or epichatechin units. Results showed that 
procyanidins were absorbed as catechins in the weaning pigs, 47% of them stayed in 
the digesta after 4 hours of feeding, when bran was previously extruded, procyanidin 
content in the sample decreased and bioavailability was improved. The degree of 
polymerization for sumac bran has been previously reported, from a total of 58.44 mg/g 
of procyanidins just 3.27 mg/g are oligomers of 1 to 3 units (Dykes and Rooney 2006). 
It is possible then that the availability of these compounds during the in vivo study 
affected the results. In bran treatments, the bulking effect of the fiber could gave more 
time in the intestine for the absorption of the compounds and therefore had better 
results.  
 
Another reason for the difference between in vitro and in vivo results could be diet 
preparation. Care was taken during formulation and preparation especially drying 
temperature control (50 and 55°C). All basic ingredients were kept constant and the 
mixing protocol standardized. However, the availability of the compounds may have 
been reduced in the process. Direct interactions between polyphenols and some 
components of food, such as binding to proteins and polysaccharides, can occur, and 
these interactions may affect absorption. Furthermore, more indirect effects of the diet 
on various parameters of gut physiology (pH, intestinal fermentations, biliary excretion, 
transit time) may have consequences on the absorption of polyphenols (Manach and 
others 2004). Kim and others (2004) suggested that weather or not a compound was 
chemopreventive depended on the diet in which the agent was administered.  
 
In vitro studies can be well controlled and standardized, in vivo studies can only be 
controlled to a certain extent, because animals are subject to external factors. However, 
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the mammalian in vivo model is by far more useful and reliable in preparation for clinical 
trials with humans.  Unfortunately, the in vivo results are inconclusive but can be useful 
for further planning.  
 
For further in vivo testing I would recommend to fractionate the methanol extract and to 
investigate a lipid fraction for potent anticancer activity. I suggest to administer the 
selected compounds to rats by gavage.  Since is possible that the anticancer properties 
are from just not one but the synergistic effect of different compounds, and because of 
the “good” results from the bran treatments, I would also suggest to repeat the 
experiment with bran, but in this case with processed (extruded) bran and to increase 
the percent in the diet to ensure the availability of the active compounds. Extrusion 
process increases bioavailability (Gu and others 2007), and sorghum bran at 2-5-5% in 
the diet could be an appropriate dose for studying health effects of sorghum 
procyanidins (Gu and others 2006).  
 
In summary, the sumac bran methanol extract did not exert the expected anticancer 
effect on the DMBA induced rats, probably because of the poor absorption or 
availability of the polyphenols. Animals fed the experimental bran diets had fewer 
incidence of tumors compared to counterparts fed the control and methanol extract 
treatments. It appeared that the bran contains certain compounds that did not solubilize 
in the 80% methanol extract that could have a positive effect in the prevention of 
mammary cancer. 
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CHAPTER V 
EVALUATION OF SUMAC SORGHUM EXTRACTS WITH A PHASE II ENZYME-
INDUCING BIOASSAY 
 
Literature Review 
 
Phase II enzymes 
 
Organisms have multiple defense systems, that ensure protection against the toxic 
effects of intrinsic and extrinsic oxidants and electrophiles to which they are exposed. 
These systems may be divided into four categories: phase 1 enzymes, phase 2 
enzymes, phase 3 efflux transporters and thiol-containing molecules (Dinkova-Kostova 
and others 2005). 
                          
 
Figure 16 - Principle of the NQ01 assay. Glucose 6-phospate and glucose-6-phosphate 
dehydrogenase generate NADPH continually. This NADPH is used by the quinone reductase to 
transfer electrons to menadione. The menadiol formed reduced MTT spontaneously, to the purple 
formazan which can be measured spectrophotometrically (Fahey and others, 2004). 
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One specific mechanism of cancer chemoprevention is the ability to induce detoxifying 
enzymes (Phase I and/or Phase II enzymes) (Wettasinghe and others 2002). 
 
Phase I enzymes, introduce functional groups onto largely hydrophobic organic 
molecules, and are usually cytochrome P450 enzymes - in some instances, these 
enzymes produce highly reactive products that are toxic to the cell. Phase II enzymes, 
such as glutathione S-transferases (GSTs) and UDP- glucuronosyl transferases, 
conjugates the products of phase I enzymes with hydrophilic groups in order to facilitate 
their excretion, and also enzymes such as superoxide dismutases, glutathione 
peroxidase, and catalase, which inactivate reactive oxygen species (Dinkova-Kostova 
and others 2005). These enzymes are key in the prevention of cancer because they act 
as blocking agents and inhibitors of tumor initiation. 
 
A simple cell culture system, developed to detect and quantitate the potency of phase II 
enzyme inducers, measures the elevation of NAD(P)H: quinone reductase (QR: a 
typical phase 2 enzyme) in murine hepatoma cells grown in 96-well microliter plates. 
This assay has been used for the isolation of the isothiocyanate sulforaphane as the 
principal and exceedingly potent monofunctional enzyme inducer in broccoli (Fahey and 
others 1997).                            
 
Figure 16 represents the principle of the NQ01 bioassay. For the test Hepa 1c1c7 line is 
used because cells have many characteristics of normal tissues, in particular the 
capacity for carcinogen activation and xenobiotic metabolism. The use of this assay has 
led to the discovery of a number of potent chemoprotective agents from plants (Fahey 
and others 2004).   
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Materials and Methods 
 
Preparation of sumac bran extracts  
 
Different extracts (3) were obtained from sumac bran for testing, including aqueous 
methanol, acidic methanol and hexane. The aqueous methanol extract was obtained as 
described previously. Procedures to obtain extracts using acidic methanol were the 
same as aqueous methanol but instead of using 80% methanol, the solvent was 1% 
HCL methanol. In these two-cases filtrates were concentrated to half the volume using 
a rotary evaporator Yamato RE200 ( Yamato Scientific America Inc., Orangeburg, N.Y. 
U.S.A.) set at 40°C. The concentrated filtrate was used for the Phase II enzyme 
bioassays. 
 
Hexane extract was obtained with some modifications of the procedure reported by 
Hwang and others (2004). Sorghum bran (50 g) was refluxed with hexane (335 ml) for 5 
h. The mixture was filtered through a coffee filter paper lying on top of a Whatman No. 2 
filter paper. The filtrate was stored at -18°C for 14 h. The cold miscella was filtered 
again through a Whatman No. 42 filter paper, and then desolventized using a rotary 
evaporator. The precipitate of long-chain lipids was collected and used for bioassay. 
 
Bioassay 
 
Induction of quinone-reductase was measured in Hepa 1c1c7 murine hepatoma cells 
grown in 96-well microtiter plates following the “Prochaska” microtiter plate bioassay for 
inducers of NQ01 (Fahey and others 2004). Stock solutions included, cultured medium, 
bioassay medium, trypsin, digitonin, dicumarol, BCA (bicinchoninic acid) and MTT (3-
[4,5-dimethylthizo-2-yl]-2,5-diphenyltetrazolium bromide; a tetrazolium dye that is 
reduced non-enzymatically by menadiol) buffers. Methanol and hexane extracts were 
concentrated at 25 and 50 mg/ml respectively, these concentrations changed because 
of the dilution with solvent and medium. For methanol extract, concentrations were 
0.13, 0.26, 0.52, 1.04, 2.08, 4.17, 8.35 and 16.7 µg/well. For hexane extract, 
concentrations evaluated were 0.15, 0.31, 0.6, 1.25. 2.5, 5, 10, and 20 µg/well. 
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Procedure 
 
Day 1. Cell culture in 96-well microtiter plates 
 
Culture medium was removed from cells (stock cells placed in petri dish at a 
concentration of 1 x 107 cells/ml); then 8 ml of phosphate buffer (PBS) was placed in 
the dish twice and discarded. A 1 ml solution of 0.05% of trypsin was added and the 
dish was placed in an incubator at 37°C and 5% CO2 for 5 min (standard conditions). 
After incubation 5 ml of maintaining medium was added to the petri dish to remove 
adhered cells. The suspension was placed in a 15 ml Falcon tube. Suspension was 
homogenized, and 1 ml aliquot was taken to perform cell quantification using the 
hematocitometer protocol. Dilutions were made to obtain 50,000 cells/ml. Medium 
containing 50,000 cells/ml was placed in a sterile reservoir and with a micropipette 200 
µl were placed in each well (96-well plaque) from column 2 to 12 leaving column 1 
empty. The plate was then placed in an incubator for 24 h at 37°C and 5% CO2 
atmosphere. 
 
Day 2. Extract addition 
 
After 24 h, to allow cells to adhere, the plate was removed from the incubator and 
medium was discarded. Culture medium was then replaced with fresh medium (20ml 
per plate) containing antibiotics to permit the introduction of non-sterile extracts. 
Depending on the solvent used to prepare extracts, methanol or DMSO (for hexane 
extraction) was added to medium in a minimum concentration to avoid cell damage 
(Table 9). Medium (150 µl) was added to all plaque columns, except column 3. Extracts 
were then placed in prepared medium in volumes according to the solvent used (Table 
9) and then added to the plate, column 3 with maximum concentration, and from 
column 4 to 10 with a dilution of 1:2 from the previous column. Plates were then 
incubated for 48 h under same conditions. 
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Table 9 – Amount of extracts and dilutions used for the Phase II Enzyme 
Bioassay 
Solvent* Minimum dilution ml of medium used to 
add test compound 
Amount of extract 
ACN 1:200 4 ml 20 µl 
Methanol 1:300 6 ml 20 µl 
THF, DMSO 1:500 4 ml 8 µl 
*ACN (acetonitrile), THF (tetrahydrofuran), DMSO (dimethyl sulfoxide). 
 
 
Day 3. BCA and MTT – Results 
 
After 48 h the plate was removed from the incubator and the medium discarded, then 
the plate was “washed” twice by placing in DPBS (Dubelcco´s Phosphate Buffered 
Saline) containing plates. DPBS was discarded and 75 µl of digitonin added to plate 
(approximately 10 ml per plate). The plate was incubated for 10 min and then agitated 
at 250 rpm for 10 min, then 20 µl from the bottom of each well were transferred to the 
correspondent column of another plate previously labeled. This new plate was filled with 
300 µl/well of BCA buffer (to measure cell density and citotoxicity) and placed in 
incubator for 30 min under standard conditions. After incubation, plate was equilibrated 
at room temperature for 15 min and then placed in the microplate, reading was made at 
550 nm.  
 
Simultaneously, MTT buffer was prepared and added (200 µl /well) to the first plate, 
after 5 min of incubation at room temperature 50 µl/well of dicumarol was added and 
reading was performed at 490 nm. Results are means of 4 measurements. The activity 
of Phase II enzymes was calculated dividing the protein concentration (absorbance 
from MTT) by the cell viability (absorbance from BCA) at different concentrations of the 
extract. One unit of inducer activity was defined as the concentration that doubles the 
specific activity of quinone reductase in a microtiter well. This concentration has been 
designated the “CD” value.  
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Results and Discussion 
 
Results from the in vivo study were inconclusive; therefore, the effect of sumac bran 
was evaluated using a different bioassay that measures the potency of phase II enzyme 
inducers, which is one specific mechanism of cancer chemoprevention.  
 
A hexane extract likely containing policosanols and lipophilic material was included in 
this part of the research to evaluate the effect of compounds not present in the 
methanolic extract but that were originally present in the bran. The choice of solvent 
and extraction protocol to isolate bioactive agents is not a trivial one, and a single 
solvent may not extract all bioactive agents from a tissue matrix (Wettansigue and 
others  2002). 
 
Figure 17 shows the behavior of the methanol sumac bran extract at three different 
days of experiments. Extract was made once, and tested three different times. The first 
time, activity results were high, however the activity changed in the second and third 
time the extract was tested. Storage of the extract was not properly done because as 
seen in the figure, some important compounds that promoted the quinone reductase 
activity were lost. Thus, only the first replicate was used for the results (Figure 18). 
 
The Sumac bran methanol extract was tested in vitro for phase II enzyme activity. 
Measured as quinone reductase, the extract induced enzymes at concentrations 
ranging from 0.13 to 16.7 µg/well (Figure 18). As concentration increased activity 
increased. A CD value (concentration of a compound required to double the QR specific 
activity in Hepa 1c1c7 murine hepatoma cells) of 0.04mg/ml was determined from the 
chart. Faulkner and others (1998) reported a CD value of 0.01mg/ml for a broccoli plant 
extract; considering broccoli has been recognized for its content of isothiocyanates, a 
very potent phase II enzyme inducers, comparatively this methanol extract induced 
phase II enzymes very effectively. It is very likely that the phenolics present in the 
extract were responsible for the induction of the quinone reductase, since extraction 
with methanol concentrates these compounds.  Some antioxidants have been 
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previously recognized as phase II enzyme inducing agents (Wettasinghe and others 
2002).  
 
 
 
 
Figure 17 - Quinone reductase activity induced by a methanol extract of sumac 
bran. Each curve represents a replicate (four determinations per replicate). 
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Figure 18 – Quinone reductase activity induced by sumac bran extract. Error bars 
denote standard error.  
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To ensure the presence of tannins, an acidic methanol extract was also tested for 
phase II enzyme activity, three different replicates were performed (data not shown). In 
two of the replicates extracts did not induce quinone reductase activity; in another 
replicate cell viability was too low to have reliable results. Thus, results were not 
conclusive and they were not included. 
 
 
 
 
Figure 19 – Quinone reductase activity induced by the hexane extract of Sumac 
bran. Curve is an average of two replicates (four determinations per replicate). 
Error bars denote standard error. 
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
1.8
2
0 5 10 15 20 25
Ac
tiv
ity
 
 
Tr
/C
tl
Concentration µg/well
CD = 0.1333 mg/ml 
70 
 
 
The hexane Sumac extract promoted activity on a range of 0.15 to 20 µg/well (Figure 
19). The extract tested was made at the beginning of the experiments and used in 
different replicates, curves obtained were similar since the components did not degrade 
under the same conditions as the hydrophilic extracts. As concentration increased 
activity also augmented. In this case, with the concentrations tested, activity of the 
enzymes could not be doubled. At maximum concentration a CD value of 0.1333 mg/ml 
was determined. The observed positive activity can be attributed to the lipophilic 
compounds of the extract. Since the extraction procedure was reported to be for 
policosanols, the policosanol content in the extract should be high; other lipophilic 
compounds probably present include phytosterols and aldehydes (Hwang and others 
2004). Policosanols are a mixture of high molecular weight aliphatic alcohols that are 
part of the wax components of the plants. Policosanols represent 19-46% of the 
sorghum wax, with octacosanol and triacontanol as the most abundant (Awika and 
Rooney 2004). Policosanols from sugarcane wax have been studied for its health 
benefits. These compounds have cholesterol-lowering properties and other positive 
benefits on lipid peroxidation.  
 
Results could be related with the observations in the in vivo experiment where bran 
diets exhibited a reduction in tumor incidence compared to methanol extract treatments 
and control. The methanol and lipid fraction present in the bran appeared to have a 
positive effect in cancer prevention by inducing phase II enzyme activity; this 
demonstrates that either alone or synergistically, bran compounds can prevent cancer.  
   
In summary, methanol and hexane extracts of sumac bran induced quinone reductase 
activity. Methanol extract was a more potent inducer of phase II enzymes than the 
hexane extract. Bran from sumac sorghum contains phytochemicals that induced 
detoxifying phase II enzymes. Phytochemicals included phenol like compounds, 
lipophilic compounds (policosanols) and other unknowns.  
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CHAPTER VI 
CONCLUSIONS 
 
For the screening part, the Sumac bran methanol extract had the highest amounts of 
phenolic compounds and tannins whereas the black sorghum methanol extract had the 
highest amount of anthocyanins. When tested in vitro against 3 different cancer cell 
lines, the methanol extracts from sumac sorghum bran inhibited 100% of mammary, 
colon and hepatic cancer cells. In general sorghum extracts inhibited more easily the 
hormone dependent mammary cancer cells, this effect could be related to a specific 
anti-estrogen compound present in the samples. 
 
The methanol extracts of sumac bran had higher percent inhibition in mammary and 
hepatic cancer cell lines than the extracts from the tannin free bran and the whole grain; 
this suggests that tannins have a citotoxic effect on MCF-7 and HepG2 cancer cells. It 
appeared that for sumac bran, tannins are partially responsible of the inhibitory effect, 
probably for its high antioxidant capacity. The Sumac bran, tannin free bran and the 
whole grain extracts had around 80% inhibition at a concentration of 0.5mg/ml on colon 
cancer cells; apparently for Caco2 cells a different compound is exerting the inhibitory 
effect. 
 
The Sumac bran methanol extracts did not inhibit the tumor incidence in female rats 
treated with DMBA. Diets containing ground bran had lower tumor incidence compared 
to the corresponding methanol extracts treatments and control group. Differences 
between in vitro and in vivo experiments could be due to phenolic compounds 
absorption, availability and changes during metabolism.  
 
Animals fed the bran diets had the lowest tumor incidence. It appeared that bran 
contains other compounds with anticancer properties different from the easily 
extractable phenolic compounds acting alone or combined. 
 
The Sumac bran methanol and hexane extracts induced phase II enzyme activities 
determined by the quinone reductase assay. Phenolic compounds and policosanols or 
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unknown compounds present in methanolic and hexane extracts respectively have the 
potential to protect against carcinogenesis by promoting detoxifying enzymes. 
 
Data from these experiments suggested that several mechanisms can be involved in 
the inhibition of carcinogenesis by sorghum phytochemicals. Phenolic compounds of 
sumac bran sorghum had a citotoxic effect on cancer cells, probably through their 
antioxidant activity; and a preventive effect as phase II enzyme inducers. Incidence of 
tumors in the in vivo experiment was reduced by the phytochemical content of the bran. 
It appeared that methanol and hexane extracts of sumac bran can prevent 
carcinogenesis by inducing phase II enzymes. 
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APPENDIX 
 
Table 9 – Total phenolics, flavonoids, anthocyanin, tannins and ORAC data for 
the screening and characterization of different sorghums for anticancer potential 
chapter 
Sample Description 
Total 
phenolics1 Flavonoids2 Anthocyanin3 Tannins2 ORAC4 
1 
ATX635 x 
RTX 436 1.49±0.06 0.3±0.02 1.32±0.00 ND 249.19 
2 SC748 2.05±0.06 0.97±0.04 3.00±1.16 ND 305.90 
3 Hegari 1.74±0.05 0.51±0.03 ND ND 91.92 
4 TX2911 1.67±0.04 1.07±0.07 ND ND 557.56 
5 
TX430 Black 
2.84±0.10 1.96±0.00 14.06±3.00 ND 331.95 
6 PI Black Tall 3.81±0.06 2.27±0.06 16.69±0.54 ND 270.76 
7 Sumac 11.98±0.18 4.00±0.14 6.87±1.50 52.09±1.62 828.95 
8 
Sumac Bran 
17.69±0.61 20.05±0.88 17.98±0.86 247.8±6.99 1133.08 
9 
TX430 Black 
Bran 8.08±0.08 6.69±0.28 67.83±6.79 ND 920.04 
10 SC719-11E 2.53±0.08 0.99±0.02 5.15±0.66 ND 621.21 
11 SC650 2.89±0.06 0.62±0.02 2.49±1.33 ND 217.18 
12 BRON 176 2.21±0.03 1.04±0.02 1.05±0.17 ND 390.08 
13 SC109-14E 1.65±0.04 0.36±0.02 ND ND 115.77 
14 
Shawaya 
(Mostly Black) 
2.83±0.01 0.91±0.02 ND ND 267.51 
15 
Shawaya 
(Brownie Tan) 
2.81±0.06 1.52±0.05 9.44±1.55 25.73±0.22 193.12 
16 NK 121 A 2.58±0.08 1.69±0.06 6.05±0.61 17.30±0.40 161.00 
17 NK 180 2.00±0.08 0.94±0.07 4.28±1.00 ND 318.39 
18 NK 8830 3.56±0.12 3.81±0.10 ND 85.9±0.60 351.35 
19 XM 217 3.13±0.12 3.38±0.12 1.69±0.00 28.52±0.81 322.18 
20 EBA 3 2.59±0.12 1.04±0.06 ND ND 978.92 
21 SC575 1.91±0.06 0.46±0.03 ND ND 963.74 
22 SC103 3.70±0.08 2.58±0.03 6.76±4.34 24.07±1.70 1053.94 
23 SC630ii 2.10±0.06 0.48±0.02 ND ND 458.03 
24 SC1038 2.46±0.09 0.57±0.00 ND ND 1087.72 
25 SC630 II 2.71±0.07 0.53±0.01 ND ND 463.14 
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Table 10 – In vitro screening of different sorghum samples data 
 
  % Inhibition 
Sample No. MCF7 CACO2 HEPG2 
1 65.73 0.00 0.00 
2 65.93 0.00 0.00 
3 68.83 0.00 0.00 
4 3.34 3.04 5.36 
5 59.00 0.00 0.00 
6 0.00 0.00 0.00 
7 0.00 0.00 1.53 
8 95.61 102.64 101.02 
9 6.87 0.00 0.00 
10 8.05 0.00 10.07 
11 0.00 0.00 0.00 
12 5.47 0.00 0.00 
13 62.41 0.00 0.00 
14 43.30 65.24 0.00 
15 1.42 0.00 0.00 
16 0.00 0.00 0.00 
17 0.00 3.84 0.00 
18 9.18 9.97 0.00 
19 10.85 3.92 0.00 
20 0.50 0.00 0.00 
21 6.42 0.00 0.00 
22 8.56 0.00 0.00 
23 0.00 0.00 0.00 
24 11.62 0.79 0.00 
25 11.23 4.11 0.05 
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